BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1224263 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C20H20N4O3S/c21-20-22-13-16(14-23-20)15-10-17(24-6-8-27-9-7-24)12-19(11-15)28(25,26)18-4-2-1-3-5-18/h1-5,10-14H,6-9H2,(H2,21,22,23) CQHLTHQSLFOTEX-UHFFFAOYSA-N 580789 5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 610 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580789&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173115 475726625 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224264 COc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C21H21N3O4S/c1-27-21-22-14-17(15-23-21)16-11-18(24-7-9-28-10-8-24)13-20(12-16)29(25,26)19-5-3-2-4-6-19/h2-6,11-15H,7-10H2,1H3 MBWFMCSQJUWQCR-UHFFFAOYSA-N 580790 4-(3-(2-methoxypyrimidin-5-yl)-5- (phenylsulfonyl)phenyl)morpholine::US11492348, Compound 2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 5000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580790&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177517 475726626 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224265 Nc1ncc(-c2cc(cc(c2)S(=O)(=O)c2ccccc2)N2CCOCC2)c(n1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c22-21(23,24)19-18(13-26-20(25)27-19)14-10-15(28-6-8-31-9-7-28)12-17(11-14)32(29,30)16-4-2-1-3-5-16/h1-5,10-13H,6-9H2,(H2,25,26,27) XSYZHBCKSOASDV-UHFFFAOYSA-N 580791 5-(3-morpholino-5-(phenylsulfonyl)phenyl)- 4-(trifluoromethyl)pyrimidin-2-amine::US11492348, Compound 3 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580791&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177518 475726627 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224266 CN(C)c1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H24N4O3S/c1-25(2)22-23-15-18(16-24-22)17-12-19(26-8-10-29-11-9-26)14-21(13-17)30(27,28)20-6-4-3-5-7-20/h3-7,12-16H,8-11H2,1-2H3 NYUAAJMMSRUYNQ-UHFFFAOYSA-N 580792 N,N-dimethyl-5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 4 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 11000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580792&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177395 475726628 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224267 COc1ccc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H22N2O4S/c1-27-22-8-7-17(16-23-22)18-13-19(24-9-11-28-12-10-24)15-21(14-18)29(25,26)20-5-3-2-4-6-20/h2-8,13-16H,9-12H2,1H3 UPEADQJVIQSWTP-UHFFFAOYSA-N 580793 4-(3-(6-methoxypyridin-3-yl)-5- (phenylsulfonyl)phenyl)morpholine::US11492348, Compound 5 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 12000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580793&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177389 475726629 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224268 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1)C(F)(F)F InChI=1S/C22H20F3N3O3S/c23-22(24,25)20-13-21(26)27-14-19(20)15-10-16(28-6-8-31-9-7-28)12-18(11-15)32(29,30)17-4-2-1-3-5-17/h1-5,10-14H,6-9H2,(H2,26,27) UECYKCXGFFAILZ-UHFFFAOYSA-N 580794 5-(3-morpholino-5-(phenylsulfonyl)phenyl)- 4-(trifluoromethyl)pyridin-2-amine::US11492348, Compound 6 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 3800 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580794&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177390 475726630 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224269 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc(c1)C(F)(F)F)N1CCOCC1 InChI=1S/C21H19F3N4O3S/c22-21(23,24)16-2-1-3-18(10-16)32(29,30)19-9-14(15-12-26-20(25)27-13-15)8-17(11-19)28-4-6-31-7-5-28/h1-3,8-13H,4-7H2,(H2,25,26,27) SLMMUVABJVMCOU-UHFFFAOYSA-N 580795 5-(3-morpholino-5-((3- (trifluoromethyl)phenyl)sulfonyl)phenyl) pyrimidin-2-amine::US11492348, Compound 7 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1800 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580795&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403583 475726631 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224270 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(F)cc1)N1CCOCC1 InChI=1S/C20H19FN4O3S/c21-16-1-3-18(4-2-16)29(26,27)19-10-14(15-12-23-20(22)24-13-15)9-17(11-19)25-5-7-28-8-6-25/h1-4,9-13H,5-8H2,(H2,22,23,24) LISIKGZNDKCXNH-UHFFFAOYSA-N 580796 5-(3-((4-fluorophenyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580796&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403593 475726632 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224271 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc2ccccc2c1)N1CCOCC1 InChI=1S/C24H22N4O3S/c25-24-26-15-20(16-27-24)19-11-21(28-7-9-31-10-8-28)14-23(13-19)32(29,30)22-6-5-17-3-1-2-4-18(17)12-22/h1-6,11-16H,7-10H2,(H2,25,26,27) QZJJCVJWBGFMJT-UHFFFAOYSA-N 580797 5-(3-morpholino-5-(naphthalen-2- ylsulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1500 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580797&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403582 475726633 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224272 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(cc1)C#N)N1CCOCC1 InChI=1S/C21H19N5O3S/c22-12-15-1-3-19(4-2-15)30(27,28)20-10-16(17-13-24-21(23)25-14-17)9-18(11-20)26-5-7-29-8-6-26/h1-4,9-11,13-14H,5-8H2,(H2,23,24,25) PQJFFUOVDUCZMA-UHFFFAOYSA-N 580798 4-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 10 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580798&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403543 475726634 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224273 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(F)c(Cl)c1)N1CCOCC1 InChI=1S/C20H18ClFN4O3S/c21-18-10-16(1-2-19(18)22)30(27,28)17-8-13(14-11-24-20(23)25-12-14)7-15(9-17)26-3-5-29-6-4-26/h1-2,7-12H,3-6H2,(H2,23,24,25) KCEIJUIZISZHPA-UHFFFAOYSA-N 580799 5-(3-((3-chloro-4-fluorophenyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 11 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1400 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580799&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403598 475726635 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224274 Cc1cnccc1-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H22N2O3S/c1-17-16-23-8-7-22(17)18-13-19(24-9-11-27-12-10-24)15-21(14-18)28(25,26)20-5-3-2-4-6-20/h2-8,13-16H,9-12H2,1H3 OCSCJTVVJRDXDP-UHFFFAOYSA-N 580800 4-(3-(3-methylpyridin-4-yl)-5- (phenylsulfonyl)phenyl)morpholine::US11492348, Compound 12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 9000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580800&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177519 475726636 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224275 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc(c1)C#N)N1CCOCC1 InChI=1S/C21H19N5O3S/c22-12-15-2-1-3-19(8-15)30(27,28)20-10-16(17-13-24-21(23)25-14-17)9-18(11-20)26-4-6-29-7-5-26/h1-3,8-11,13-14H,4-7H2,(H2,23,24,25) NOVSQOKURKTTHJ-UHFFFAOYSA-N 580801 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 910 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580801&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403550 475726637 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224276 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(cc1)C(F)(F)F)N1CCOCC1 InChI=1S/C21H19F3N4O3S/c22-21(23,24)16-1-3-18(4-2-16)32(29,30)19-10-14(15-12-26-20(25)27-13-15)9-17(11-19)28-5-7-31-8-6-28/h1-4,9-13H,5-8H2,(H2,25,26,27) VXXBWOAQJWBSHM-UHFFFAOYSA-N 580802 5-(3-morpholino-5-((4- (trifluoromethyl)phenyl)sulfonyl)phenyl) pyrimidin-2-amine::US11492348, Compound 14 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 7300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580802&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403566 475726638 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224277 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(OC(F)(F)F)cc1)N1CCOCC1 InChI=1S/C21H19F3N4O4S/c22-21(23,24)32-17-1-3-18(4-2-17)33(29,30)19-10-14(15-12-26-20(25)27-13-15)9-16(11-19)28-5-7-31-8-6-28/h1-4,9-13H,5-8H2,(H2,25,26,27) GNRZQAOZAOLONJ-UHFFFAOYSA-N 580803 5-(3-morpholino-5-((4- (trifluoromethoxy)phenyl)sulfonyl)phenyl) pyrimidin-2-amine::US11492348, Compound 15 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 3500 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580803&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403591 475726639 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224278 CNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C21H22N4O3S/c1-22-21-23-14-17(15-24-21)16-11-18(25-7-9-28-10-8-25)13-20(12-16)29(26,27)19-5-3-2-4-6-19/h2-6,11-15H,7-10H2,1H3,(H,22,23,24) ZHVMBURQTMKZOC-UHFFFAOYSA-N 580804 N-methyl-5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 16 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1500 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580804&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403540 475726640 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224279 Nc1ncc(-c2cc(cc(c2)S(=O)(=O)c2ccc(cc2)C#N)N2CCOCC2)c(n1)C(F)(F)F InChI=1S/C22H18F3N5O3S/c23-22(24,25)20-19(13-28-21(27)29-20)15-9-16(30-5-7-33-8-6-30)11-18(10-15)34(31,32)17-3-1-14(12-26)2-4-17/h1-4,9-11,13H,5-8H2,(H2,27,28,29) UOIGQFPHLCWPGS-UHFFFAOYSA-N 580805 4-((3-(2-amino-4- (trifluoromethyl)pyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 17 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580805&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403592 475726641 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224280 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(cc1)C#N)N1CCOCC1)C(F)(F)F InChI=1S/C23H19F3N4O3S/c24-23(25,26)21-12-22(28)29-14-20(21)16-9-17(30-5-7-33-8-6-30)11-19(10-16)34(31,32)18-3-1-15(13-27)2-4-18/h1-4,9-12,14H,5-8H2,(H2,28,29) BIVPSVOHMHKNQJ-UHFFFAOYSA-N 580806 4-((3-(6-amino-4-(trifluoromethyl)pyridin-3- yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 18 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 3900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580806&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177520 475726642 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224281 OCCNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H24N4O4S/c27-9-6-23-22-24-15-18(16-25-22)17-12-19(26-7-10-30-11-8-26)14-21(13-17)31(28,29)20-4-2-1-3-5-20/h1-5,12-16,27H,6-11H2,(H,23,24,25) UXVRSRKRBBLSJY-UHFFFAOYSA-N 580807 2-((5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2- yl)amino)ethan-1-ol::US11492348, Compound 19 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580807&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403556 475726643 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224282 O=S(=O)(c1ccccc1)c1cc(cc(c1)-c1cnc(NC2CC2)nc1)N1CCOCC1 InChI=1S/C23H24N4O3S/c28-31(29,21-4-2-1-3-5-21)22-13-17(12-20(14-22)27-8-10-30-11-9-27)18-15-24-23(25-16-18)26-19-6-7-19/h1-5,12-16,19H,6-11H2,(H,24,25,26) AVSDJUUZCZSIGH-UHFFFAOYSA-N 580808 N-cyclopropyl-5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 20 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2700 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580808&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403564 475726644 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224283 Cc1ccc(cc1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H22N4O3S/c1-15-2-4-19(5-3-15)29(26,27)20-11-16(17-13-23-21(22)24-14-17)10-18(12-20)25-6-8-28-9-7-25/h2-5,10-14H,6-9H2,1H3,(H2,22,23,24) KOGZQRMLAGNKRT-UHFFFAOYSA-N 580809 5-(3-morpholino-5-tosylphenyl)pyrimidin-2- amine::US11492348, Compound 21 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580809&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403563 475726645 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224284 CC(=O)Nc1ccc(cc1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H23N5O4S/c1-15(28)26-18-2-4-20(5-3-18)32(29,30)21-11-16(17-13-24-22(23)25-14-17)10-19(12-21)27-6-8-31-9-7-27/h2-5,10-14H,6-9H2,1H3,(H,26,28)(H2,23,24,25) JVZHZEZJQFVOIZ-UHFFFAOYSA-N 580810 N-(4-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)phenyl)acetamide::US11492348, Compound 22 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2800 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580810&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403567 475726646 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224285 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1 InChI=1S/C21H22N4O3S/c22-21-23-13-18(14-24-21)17-10-19(25-6-8-28-9-7-25)12-20(11-17)29(26,27)15-16-4-2-1-3-5-16/h1-5,10-14H,6-9,15H2,(H2,22,23,24) AXSUJMFUIXJCLT-UHFFFAOYSA-N 580811 5-(3-(benzylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 23 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 100.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580811&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403565 475726647 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224286 CC(C)(C)OC(=O)N1CCN(CC1)c1cc(cc(c1)S(=O)(=O)c1ccccc1)-c1cnc(N)nc1 InChI=1S/C25H29N5O4S/c1-25(2,3)34-24(31)30-11-9-29(10-12-30)20-13-18(19-16-27-23(26)28-17-19)14-22(15-20)35(32,33)21-7-5-4-6-8-21/h4-8,13-17H,9-12H2,1-3H3,(H2,26,27,28) TYPIBMQSGMPJJC-UHFFFAOYSA-N 580812 US11492348, Compound 24::tert-butyl 4-(3-(2-aminopyrimidin-5-yl)-5- (phenylsulfonyl)phenyl)piperazine-1- carboxylate Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 21000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580812&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177506 475726648 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224287 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCCCC1 InChI=1S/C21H22N4O2S/c22-21-23-14-17(15-24-21)16-11-18(25-9-5-2-6-10-25)13-20(12-16)28(26,27)19-7-3-1-4-8-19/h1,3-4,7-8,11-15H,2,5-6,9-10H2,(H2,22,23,24) DUUHATBCMITMAR-UHFFFAOYSA-N 580813 5-(3-(phenylsulfonyl)-5-(piperidin-1- yl)phenyl)pyrimidin-2-amine::US11492348, Compound 25 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 30000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580813&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177507 475726649 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224288 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1F)N1CCOCC1 InChI=1S/C21H20F2N4O3S/c22-17-2-1-14(20(23)9-17)13-31(28,29)19-8-15(16-11-25-21(24)26-12-16)7-18(10-19)27-3-5-30-6-4-27/h1-2,7-12H,3-6,13H2,(H2,24,25,26) BSWWWMIFNUFSMO-UHFFFAOYSA-N 580814 5-(3-((2,4-difluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 26 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 270 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580814&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403542 475726650 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224289 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1cccc(c1)C#N)N1CCOCC1 InChI=1S/C22H21N5O3S/c23-12-16-2-1-3-17(8-16)15-31(28,29)21-10-18(19-13-25-22(24)26-14-19)9-20(11-21)27-4-6-30-7-5-27/h1-3,8-11,13-14H,4-7,15H2,(H2,24,25,26) KEVLFKYIMJFLKZ-UHFFFAOYSA-N 580815 3-(((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)methyl) benzonitrile::US11492348, Compound 27 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 380 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580815&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403568 475726651 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224290 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(CO)cc1)N1CCOCC1 InChI=1S/C22H24N4O4S/c23-22-24-12-19(13-25-22)18-9-20(26-5-7-30-8-6-26)11-21(10-18)31(28,29)15-17-3-1-16(14-27)2-4-17/h1-4,9-13,27H,5-8,14-15H2,(H2,23,24,25) HEXZJRXLBPGLGP-UHFFFAOYSA-N 580816 5-(3-((4-methoxybenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 28 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 370 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580816&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 158459048 475726652 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224291 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C21H21FN4O3S/c22-18-3-1-15(2-4-18)14-30(27,28)20-10-16(17-12-24-21(23)25-13-17)9-19(11-20)26-5-7-29-8-6-26/h1-4,9-13H,5-8,14H2,(H2,23,24,25) DINYTTSGCRGAJR-UHFFFAOYSA-N 580817 5-(3-((4-fluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 29 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 370 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580817&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403541 475726653 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224292 CC(=O)Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H22N4O4S/c1-16(27)25-22-23-14-18(15-24-22)17-11-19(26-7-9-30-10-8-26)13-21(12-17)31(28,29)20-5-3-2-4-6-20/h2-6,11-15H,7-10H2,1H3,(H,23,24,25,27) UTJHTHZLECYYPO-UHFFFAOYSA-N 580818 N-(5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2- yl)acetamide::US11492348, Compound 30 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 3100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580818&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403547 475726654 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224293 CNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1 InChI=1S/C22H24N4O3S/c1-23-22-24-14-19(15-25-22)18-11-20(26-7-9-29-10-8-26)13-21(12-18)30(27,28)16-17-5-3-2-4-6-17/h2-6,11-15H,7-10,16H2,1H3,(H,23,24,25) ITHJJWJNHFLZAK-UHFFFAOYSA-N 580819 5-(3-(benzylsulfonyl)-5-morpholinophenyl)- N-methylpyrimidin-2-amine::US11492348, Compound 31 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 660 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580819&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403548 475726655 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224294 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1)C(F)(F)F InChI=1S/C23H22F3N3O3S/c24-23(25,26)21-13-22(27)28-14-20(21)17-10-18(29-6-8-32-9-7-29)12-19(11-17)33(30,31)15-16-4-2-1-3-5-16/h1-5,10-14H,6-9,15H2,(H2,27,28) LVHZEQFUPUPOLU-UHFFFAOYSA-N 580820 5-(3-(benzylsulfonyl)-5-morpholinophenyl)- 4-(trifluoromethyl)pyridin-2-amine::US11492348, Compound 32 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 450 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580820&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177561 475726656 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224295 Nc1ncc(-c2cc(cc(c2)S(=O)(=O)Cc2ccccc2)N2CCOCC2)c(n1)C(F)(F)F InChI=1S/C22H21F3N4O3S/c23-22(24,25)20-19(13-27-21(26)28-20)16-10-17(29-6-8-32-9-7-29)12-18(11-16)33(30,31)14-15-4-2-1-3-5-15/h1-5,10-13H,6-9,14H2,(H2,26,27,28) HBWOBXLZXBKWBD-UHFFFAOYSA-N 580821 5-(3-(benzylsulfonyl)-5-morpholinophenyl)- 4-(trifluoromethyl)pyrimidin-2-amine::US11492348, Compound 33 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 980 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580821&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403577 475726657 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224296 Cc1cn2cc(cnc2n1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1 InChI=1S/C24H24N4O3S/c1-18-15-28-16-21(14-25-24(28)26-18)20-11-22(27-7-9-31-10-8-27)13-23(12-20)32(29,30)17-19-5-3-2-4-6-19/h2-6,11-16H,7-10,17H2,1H3 ADLPRZLKGJDZJU-UHFFFAOYSA-N 580822 4-(3-(benzylsulfonyl)-5-(2- methylimidazo[1,2-a]pyrimidin-6- yl)phenyl)morpholine::US11492348, Compound 34 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 13000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580822&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403586 475726658 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224297 OCCNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1 InChI=1S/C23H26N4O4S/c28-9-6-24-23-25-15-20(16-26-23)19-12-21(27-7-10-31-11-8-27)14-22(13-19)32(29,30)17-18-4-2-1-3-5-18/h1-5,12-16,28H,6-11,17H2,(H,24,25,26) AUFXEJFFYMFFGA-UHFFFAOYSA-N 580823 2-((5-(3-(benzylsulfonyl)-5- morpholinophenyl)pyrimidin-2- yl)amino)ethan-1-ol::US11492348, Compound 35 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580823&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403539 475726659 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224298 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(cc1)N1CCOCC1)N1CCOCC1 InChI=1S/C24H27N5O4S/c25-24-26-16-19(17-27-24)18-13-21(29-7-11-33-12-8-29)15-23(14-18)34(30,31)22-3-1-20(2-4-22)28-5-9-32-10-6-28/h1-4,13-17H,5-12H2,(H2,25,26,27) QORVXHFVBZYUAW-UHFFFAOYSA-N 580824 5-(3-morpholino-5-((4- morpholinophenyl)sulfonyl)phenyl) pyrimidin-2-amine::US11492348, Compound 36 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580824&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177546 475726660 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224299 CC(C)(O)CNc1ccc(cc1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C24H29N5O4S/c1-24(2,30)16-28-19-3-5-21(6-4-19)34(31,32)22-12-17(18-14-26-23(25)27-15-18)11-20(13-22)29-7-9-33-10-8-29/h3-6,11-15,28,30H,7-10,16H2,1-2H3,(H2,25,26,27) GDQGPAHJFFPPJX-UHFFFAOYSA-N 580825 1-((4-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)phenyl)amino)- 2-methylpropan-2-ol::US11492348, Compound 37 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580825&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403559 475726661 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224300 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CC1CCOC1)N1CCOCC1 InChI=1S/C19H24N4O4S/c20-19-21-10-16(11-22-19)15-7-17(23-2-5-26-6-3-23)9-18(8-15)28(24,25)13-14-1-4-27-12-14/h7-11,14H,1-6,12-13H2,(H2,20,21,22) PBDNSQIGSLIDQF-UHFFFAOYSA-N 580826 5-(3-morpholino-5-(((tetrahydrofuran-3- yl)methyl)sulfonyl)phenyl)pyrimidin-2- amine::US11492348, Compound 38 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 740 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580826&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173124 475726662 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224301 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CC1CCOCC1)N1CCOCC1 InChI=1S/C20H26N4O4S/c21-20-22-12-17(13-23-20)16-9-18(24-3-7-28-8-4-24)11-19(10-16)29(25,26)14-15-1-5-27-6-2-15/h9-13,15H,1-8,14H2,(H2,21,22,23) FKLPBMTYUBSJAH-UHFFFAOYSA-N 580827 5-(3-morpholino-5-(((tetrahydro-2H-pyran- 4-yl)methyl)sulfonyl)phenyl)pyrimidin-2- amine::US11492348, Compound 39 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 790 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580827&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403575 475726663 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224302 CCNC(=O)Nc1ccc(cc1OC)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C27H30FN3O5S/c1-3-29-27(32)30-25-9-6-20(16-26(25)35-2)21-14-23(31-10-12-36-13-11-31)17-24(15-21)37(33,34)18-19-4-7-22(28)8-5-19/h4-9,14-17H,3,10-13,18H2,1-2H3,(H2,29,30,32) IMHPLCQACGUQQA-UHFFFAOYSA-N 580828 1-ethyl-3-(3'-((4-fluorobenzyl)sulfonyl)-3- methoxy-5'-morpholino-[1,1'-biphenyl]-4- yl)urea::US11492348, Compound 40 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 6500 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580828&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177454 475726664 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224303 Oc1cccc(c1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C23H22FNO4S/c24-20-6-4-17(5-7-20)16-30(27,28)23-14-19(18-2-1-3-22(26)13-18)12-21(15-23)25-8-10-29-11-9-25/h1-7,12-15,26H,8-11,16H2 GNPGNLUFMXYLDV-UHFFFAOYSA-N 580829 3'-((4-fluorobenzyl)sulfonyl)-5'-morpholino- [1,1'-biphenyl]-3-ol::US11492348, Compound 41 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 530 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580829&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177453 475726665 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224304 Fc1ccc(CS(=O)(=O)c2cc(cc(c2)-c2ccc3NC(=O)COc3c2)N2CCOCC2)cc1 InChI=1S/C25H23FN2O5S/c26-20-4-1-17(2-5-20)16-34(30,31)22-12-19(11-21(14-22)28-7-9-32-10-8-28)18-3-6-23-24(13-18)33-15-25(29)27-23/h1-6,11-14H,7-10,15-16H2,(H,27,29) JTBYJRPQGPZWAX-UHFFFAOYSA-N 580830 7-(3-((4-fluorobenzyl)sulfonyl)-5- morpholinophenyl)-2H-benzo[b][1,4]oxazin- 3(4H)-one::US11492348, Compound 42 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 4700 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580830&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177451 475726666 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224305 COc1ccc(cc1N)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C24H25FN2O4S/c1-30-24-7-4-18(14-23(24)26)19-12-21(27-8-10-31-11-9-27)15-22(13-19)32(28,29)16-17-2-5-20(25)6-3-17/h2-7,12-15H,8-11,16,26H2,1H3 ILTVOUQQXGCQGW-UHFFFAOYSA-N 580831 3'-((4-fluorobenzyl)sulfonyl)-4-methoxy-5'- morpholino-[1,1'-biphenyl]-3-amine::US11492348, Compound 43 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 11000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580831&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177456 475726667 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224306 COc1nc(N)ccc1-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C23H24FN3O4S/c1-30-23-21(6-7-22(25)26-23)17-12-19(27-8-10-31-11-9-27)14-20(13-17)32(28,29)15-16-2-4-18(24)5-3-16/h2-7,12-14H,8-11,15H2,1H3,(H2,25,26) WZMVFQRIYHIECU-UHFFFAOYSA-N 580832 5-(3-((4-fluorobenzyl)sulfonyl)-5- morpholinophenyl)-6-methoxypyridin-2- amine::US11492348, Compound 44 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 13000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580832&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177397 475726668 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224307 Fc1ccc(CS(=O)(=O)c2cc(cc(c2)-c2ccc3NCCOc3c2)N2CCOCC2)cc1 InChI=1S/C25H25FN2O4S/c26-21-4-1-18(2-5-21)17-33(29,30)23-14-20(13-22(16-23)28-8-11-31-12-9-28)19-3-6-24-25(15-19)32-10-7-27-24/h1-6,13-16,27H,7-12,17H2 NLBYCUXABQDWDS-UHFFFAOYSA-N 580833 7-(3-((4-fluorobenzyl)sulfonyl)-5- morpholinophenyl)-3,4-dihydro-2H- benzo[b][1,4]oxazine::US11492348, Compound 45 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 5900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580833&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177396 475726669 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224308 Fc1ccc(CS(=O)(=O)c2cc(cc(c2)-c2cccc(OC(F)(F)F)c2)N2CCOCC2)cc1 InChI=1S/C24H21F4NO4S/c25-20-6-4-17(5-7-20)16-34(30,31)23-14-19(12-21(15-23)29-8-10-32-11-9-29)18-2-1-3-22(13-18)33-24(26,27)28/h1-7,12-15H,8-11,16H2 BUDHTFYQAGPSFF-UHFFFAOYSA-N 580834 4-(5-((4-fluorobenzyl)sulfonyl)-3'- (trifluoromethoxy)-[1,1'-biphenyl]-3- yl)morpholine::US11492348, Compound 46 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 19000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580834&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177398 475726670 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224309 NCCNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C23H26FN5O3S/c24-20-3-1-17(2-4-20)16-33(30,31)22-12-18(11-21(13-22)29-7-9-32-10-8-29)19-14-27-23(28-15-19)26-6-5-25/h1-4,11-15H,5-10,16,25H2,(H,26,27,28) SQJXKDBFQOBHDB-UHFFFAOYSA-N 580835 N1-(5-(3-((4-fluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-yl)ethane- 1,2-diamine::US11492348, Compound 47 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1200 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580835&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177391 475726671 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224310 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1c[nH]c2ccccc12)N1CCOCC1 InChI=1S/C23H23N5O3S/c24-23-26-12-17(13-27-23)16-9-19(28-5-7-31-8-6-28)11-20(10-16)32(29,30)15-18-14-25-22-4-2-1-3-21(18)22/h1-4,9-14,25H,5-8,15H2,(H2,24,26,27) UEARLLHPZNDKJH-UHFFFAOYSA-N 580836 5-(3-(((1H-indol-3-yl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 48 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 470 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580836&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403544 475726672 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224311 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCCCC1)N1CCOCC1 InChI=1S/C20H26N4O3S/c21-20-22-13-16(14-23-20)15-10-17(24-6-8-27-9-7-24)12-19(11-15)28(25,26)18-4-2-1-3-5-18/h10-14,18H,1-9H2,(H2,21,22,23) KDLQRPLIGSYUGT-UHFFFAOYSA-N 580837 5-(3-(cyclohexylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 49 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 490 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580837&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177399 475726673 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224312 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1F)N1CCOCC1 InChI=1S/C21H21FN4O3S/c22-20-4-2-1-3-15(20)14-30(27,28)19-10-16(17-12-24-21(23)25-13-17)9-18(11-19)26-5-7-29-8-6-26/h1-4,9-13H,5-8,14H2,(H2,23,24,25) QAAKCQGAMWFSQA-UHFFFAOYSA-N 580838 5-(3-((2-fluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 50 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 280 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580838&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403585 475726674 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224313 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-20-10-14(11-21-18)13-7-15(22-2-5-25-6-3-22)9-17(8-13)27(23,24)16-1-4-26-12-16/h7-11,16H,1-6,12H2,(H2,19,20,21) JOSFJDYSRMQQQE-UHFFFAOYSA-N 580839 5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 51 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 120 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580839&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173036 475726675 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224314 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-20-10-14(11-21-18)13-7-15(22-2-5-25-6-3-22)9-17(8-13)27(23,24)16-1-4-26-12-16/h7-11,16H,1-6,12H2,(H2,19,20,21)/t16-/m1/s1 JOSFJDYSRMQQQE-MRXNPFEDSA-N 580840 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 52 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 130 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580840&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173035 475726676 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224315 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@H]1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-20-10-14(11-21-18)13-7-15(22-2-5-25-6-3-22)9-17(8-13)27(23,24)16-1-4-26-12-16/h7-11,16H,1-6,12H2,(H2,19,20,21)/t16-/m0/s1 JOSFJDYSRMQQQE-INIZCTEOSA-N 580841 (S)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 53 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 110 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580841&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177521 475726677 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224316 CC(C)(C)OC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H29N5O5S/c1-22(2,3)32-21(28)27-13-19(14-27)33(29,30)18-9-15(16-11-24-20(23)25-12-16)8-17(10-18)26-4-6-31-7-5-26/h8-12,19H,4-7,13-14H2,1-3H3,(H2,23,24,25) BYFFRDOLDMUBDX-UHFFFAOYSA-N 580842 US11492348, Compound 54::tert-butyl 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidine-1- carboxylate Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 130 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580842&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173019 475726678 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224317 COc1cncc(c1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C23H23FN2O4S/c1-29-22-11-19(14-25-15-22)18-10-21(26-6-8-30-9-7-26)13-23(12-18)31(27,28)16-17-2-4-20(24)5-3-17/h2-5,10-15H,6-9,16H2,1H3 QVCIRWYMHHEMFD-UHFFFAOYSA-N 580843 4-(3-((4-fluorobenzyl)sulfonyl)-5-(5- methoxypyridin-3-yl)phenyl)morpholine::US11492348, Compound 55 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 12000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580843&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177522 475726679 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224318 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc2[nH]ccc2c1)N1CCOCC1 InChI=1S/C23H23N5O3S/c24-23-26-13-19(14-27-23)18-10-20(28-5-7-31-8-6-28)12-21(11-18)32(29,30)15-16-1-2-22-17(9-16)3-4-25-22/h1-4,9-14,25H,5-8,15H2,(H2,24,26,27) XJDISKLIAOIKHD-UHFFFAOYSA-N 580844 5-(3-(((1H-indol-5-yl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 56 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 260 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580844&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177523 475726680 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224319 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(NS(N)(=O)=O)cc1)N1CCOCC1 InChI=1S/C21H24N6O5S2/c22-21-24-12-17(13-25-21)16-9-19(27-5-7-32-8-6-27)11-20(10-16)33(28,29)14-15-1-3-18(4-2-15)26-34(23,30)31/h1-4,9-13,26H,5-8,14H2,(H2,22,24,25)(H2,23,30,31) AIEZAQLQTGRIBK-UHFFFAOYSA-N 580845 N-(4-(((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)methyl)phenyl) methanesulfonamide::US11492348, Compound 57 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 480 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580845&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 166594436 475726681 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224320 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(cc1)N1CCOCC1)N1CCOCC1 InChI=1S/C25H29N5O4S/c26-25-27-16-21(17-28-25)20-13-23(30-7-11-34-12-8-30)15-24(14-20)35(31,32)18-19-1-3-22(4-2-19)29-5-9-33-10-6-29/h1-4,13-17H,5-12,18H2,(H2,26,27,28) LVUSAPAAXSOAIN-UHFFFAOYSA-N 580846 5-(3-morpholino-5-((4- morpholinobenzyl)sulfonyl)phenyl) pyrimidin-2-amine::US11492348, Compound 58 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 410 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580846&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177568 475726682 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224321 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1c[nH]cn1)N1CCOCC1 InChI=1S/C18H20N6O3S/c19-18-21-8-14(9-22-18)13-5-16(24-1-3-27-4-2-24)7-17(6-13)28(25,26)11-15-10-20-12-23-15/h5-10,12H,1-4,11H2,(H,20,23)(H2,19,21,22) FXBITLRVSYFNLQ-UHFFFAOYSA-N 580847 5-(3-(((1H-imidazol-4-yl)methyl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 59 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580847&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403589 475726683 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224322 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CC1CCCCC1)N1CCOCC1 InChI=1S/C21H28N4O3S/c22-21-23-13-18(14-24-21)17-10-19(25-6-8-28-9-7-25)12-20(11-17)29(26,27)15-16-4-2-1-3-5-16/h10-14,16H,1-9,15H2,(H2,22,23,24) UGNHRUPSHOBCAE-UHFFFAOYSA-N 580848 5-(3-((cyclohexylmethyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 60 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 810 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580848&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403572 475726684 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224323 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CNC1)N1CCOCC1 InChI=1S/C17H21N5O3S/c18-17-20-8-13(9-21-17)12-5-14(22-1-3-25-4-2-22)7-15(6-12)26(23,24)16-10-19-11-16/h5-9,16,19H,1-4,10-11H2,(H2,18,20,21) IBIZATYPAVCKDO-UHFFFAOYSA-N 580849 5-(3-(azetidin-3-ylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 61 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 500 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580849&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173039 475726685 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224324 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOCC1)N1CCOCC1 InChI=1S/C19H24N4O4S/c20-19-21-12-15(13-22-19)14-9-16(23-3-7-27-8-4-23)11-18(10-14)28(24,25)17-1-5-26-6-2-17/h9-13,17H,1-8H2,(H2,20,21,22) MNXDJZUAFAEDPV-UHFFFAOYSA-N 580850 5-(3-morpholino-5-((tetrahydro-2H-pyran-4- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 62 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 330 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580850&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403554 475726686 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224325 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc2[nH]cnc2c1)N1CCOCC1 InChI=1S/C22H22N6O3S/c23-22-24-11-17(12-25-22)16-8-18(28-3-5-31-6-4-28)10-19(9-16)32(29,30)13-15-1-2-20-21(7-15)27-14-26-20/h1-2,7-12,14H,3-6,13H2,(H,26,27)(H2,23,24,25) QSULAKNUOMLTTH-UHFFFAOYSA-N 580851 5-(3-(((1H-benzo[d]imidazol-5- yl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 63 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 470 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580851&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177565 475726687 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224326 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CC1CCC(F)(F)CC1)N1CCOCC1 InChI=1S/C21H26F2N4O3S/c22-21(23)3-1-15(2-4-21)14-31(28,29)19-10-16(17-12-25-20(24)26-13-17)9-18(11-19)27-5-7-30-8-6-27/h9-13,15H,1-8,14H2,(H2,24,25,26) LLZHOGQVPCMBMG-UHFFFAOYSA-N 580852 5-(3-(((4,4- difluorocyclohexyl)methyl)sulfonyl)-5- C21H26F2N4O3Smorpholinophenyl) pyrimidin-2-amine::US11492348, Compound 64 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580852&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177562 475726688 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224327 CC(C)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H27N5O3S/c1-14(2)25-12-19(13-25)29(26,27)18-8-15(16-10-22-20(21)23-11-16)7-17(9-18)24-3-5-28-6-4-24/h7-11,14,19H,3-6,12-13H2,1-2H3,(H2,21,22,23) NZRUDHORANOEMB-UHFFFAOYSA-N 580853 5-(3-((1-isopropylazetidin-3-yl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 65 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 870 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580853&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177574 475726689 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224328 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CN(C1)C1CCOCC1)N1CCOCC1 InChI=1S/C22H29N5O4S/c23-22-24-12-17(13-25-22)16-9-19(26-3-7-31-8-4-26)11-20(10-16)32(28,29)21-14-27(15-21)18-1-5-30-6-2-18/h9-13,18,21H,1-8,14-15H2,(H2,23,24,25) JRAOKCVZUPWKFE-UHFFFAOYSA-N 580854 5-(3-morpholino-5-((1-(tetrahydro-2H- pyran-4-yl)azetidin-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 66 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580854&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403553 475726690 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224329 CC(C)(C)OC(=O)N1CCC(CC1)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C27H38N6O5S/c1-27(2,3)38-26(34)32-6-4-21(5-7-32)33-17-24(18-33)39(35,36)23-13-19(20-15-29-25(28)30-16-20)12-22(14-23)31-8-10-37-11-9-31/h12-16,21,24H,4-11,17-18H2,1-3H3,(H2,28,29,30) QCXHSBPQFQAHJS-UHFFFAOYSA-N 580855 US11492348, Compound 67::tert-butyl 4-(3-((3-(2-aminopyrimidin-5-yl)- 5-morpholinophenyl)sulfonyl)azetidin-1- yl)piperidine-1-carboxylate Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 800 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580855&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403581 475726691 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224330 CC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C19H23N5O4S/c1-13(25)24-11-18(12-24)29(26,27)17-7-14(15-9-21-19(20)22-10-15)6-16(8-17)23-2-4-28-5-3-23/h6-10,18H,2-5,11-12H2,1H3,(H2,20,21,22) REVVXZMXEHLSOS-UHFFFAOYSA-N 580856 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1- yl)ethan-1-one::US11492348, Compound 68 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 47.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580856&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177412 475726692 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224331 CC(C)(C)OC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)cn1)N1CCOCC1 InChI=1S/C22H29N5O5S/c1-22(2,3)32-21(28)27-13-18(14-27)33(29,30)17-9-15(19-11-25-20(23)12-24-19)8-16(10-17)26-4-6-31-7-5-26/h8-12,18H,4-7,13-14H2,1-3H3,(H2,23,25) VVNBBGRJUHXRIN-UHFFFAOYSA-N 580857 US11492348, Compound 69::tert-butyl 3-((3-(5-aminopyrazin-2-yl)-5- morpholinophenyl)sulfonyl)azetidine-1- carboxylate Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 540 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580857&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403545 475726693 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224332 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOC1)N1CCOCC1)C(F)(F)F InChI=1S/C20H22F3N3O4S/c21-20(22,23)18-10-19(24)25-11-17(18)13-7-14(26-2-5-29-6-3-26)9-16(8-13)31(27,28)15-1-4-30-12-15/h7-11,15H,1-6,12H2,(H2,24,25) ABFSEKIPQPPYFD-UHFFFAOYSA-N 580858 5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-4- (trifluoromethyl)pyridin-2-amine::US11492348, Compound 70 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 7600 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580858&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177452 475726694 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224333 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1)C(F)(F)F InChI=1S/C20H22F3N3O4S/c21-20(22,23)18-10-19(24)25-11-17(18)13-7-14(26-2-5-29-6-3-26)9-16(8-13)31(27,28)15-1-4-30-12-15/h7-11,15H,1-6,12H2,(H2,24,25)/t15-/m1/s1 ABFSEKIPQPPYFD-OAHLLOKOSA-N 580859 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-4- (trifluoromethyl)pyridin-2-amine::US11492348, Compound 71 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 9100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580859&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177455 475726695 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224334 Nc1ncc(-c2cc(cc(c2)S(=O)(=O)C2CCOC2)N2CCOCC2)c(n1)C(F)(F)F InChI=1S/C19H21F3N4O4S/c20-19(21,22)17-16(10-24-18(23)25-17)12-7-13(26-2-5-29-6-3-26)9-15(8-12)31(27,28)14-1-4-30-11-14/h7-10,14H,1-6,11H2,(H2,23,24,25) CMGJJOGJVKPERQ-UHFFFAOYSA-N 580860 5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-4- (trifluoromethyl)pyrimidin-2-amine::US11492348, Compound 72 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580860&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177509 475726696 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224335 Nc1cnc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1 InChI=1S/C21H22N4O3S/c22-21-14-23-20(13-24-21)17-10-18(25-6-8-28-9-7-25)12-19(11-17)29(26,27)15-16-4-2-1-3-5-16/h1-5,10-14H,6-9,15H2,(H2,22,24) DJOANDWLBWYWFD-UHFFFAOYSA-N 580861 5-(3-(benzylsulfonyl)-5- morpholinophenyl)pyrazin-2-amine::US11492348, Compound 73 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1500 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580861&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177510 475726697 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224336 Nc1cnc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-11-20-17(10-21-18)13-7-14(22-2-5-25-6-3-22)9-16(8-13)27(23,24)15-1-4-26-12-15/h7-11,15H,1-6,12H2,(H2,19,21) CIJLGCSDHLXUBA-UHFFFAOYSA-N 580862 5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrazin-2-amine::US11492348, Compound 74 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580862&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177508 475726698 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224337 CCC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H25N5O4S/c1-2-19(26)25-12-18(13-25)30(27,28)17-8-14(15-10-22-20(21)23-11-15)7-16(9-17)24-3-5-29-6-4-24/h7-11,18H,2-6,12-13H2,1H3,(H2,21,22,23) MYSAQBRFMVZHGR-UHFFFAOYSA-N 580863 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1- yl)propan-1-one::US11492348, Compound 75 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 250 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580863&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403595 475726699 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224338 CC(C)C(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H27N5O4S/c1-14(2)20(27)26-12-19(13-26)31(28,29)18-8-15(16-10-23-21(22)24-11-16)7-17(9-18)25-3-5-30-6-4-25/h7-11,14,19H,3-6,12-13H2,1-2H3,(H2,22,23,24) SMNRAFUKBPHRSF-UHFFFAOYSA-N 580864 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1-yl)-2- methylpropan-1-one::US11492348, Compound 76 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580864&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403580 475726700 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224339 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CN(C1)C(=O)C1CC1)N1CCOCC1 InChI=1S/C21H25N5O4S/c22-21-23-10-16(11-24-21)15-7-17(25-3-5-30-6-4-25)9-18(8-15)31(28,29)19-12-26(13-19)20(27)14-1-2-14/h7-11,14,19H,1-6,12-13H2,(H2,22,23,24) GQPLKKMMMCWSGR-UHFFFAOYSA-N 580865 (3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1- yl)(cyclopropyl)methanone::US11492348, Compound 77 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 100.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580865&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173230 475726701 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224340 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CN(C1)C(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C25H26FN5O4S/c26-20-3-1-17(2-4-20)9-24(32)31-15-23(16-31)36(33,34)22-11-18(19-13-28-25(27)29-14-19)10-21(12-22)30-5-7-35-8-6-30/h1-4,10-14,23H,5-9,15-16H2,(H2,27,28,29) BKEZTGYVYYPAKU-UHFFFAOYSA-N 580866 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1-yl)-2- (4-fluorophenyl)ethan-1-one::US11492348, Compound 78 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 180 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580866&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403587 475726702 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224341 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CN(C1)C(=O)c1ccc(F)cc1)N1CCOCC1 InChI=1S/C24H24FN5O4S/c25-19-3-1-16(2-4-19)23(31)30-14-22(15-30)35(32,33)21-10-17(18-12-27-24(26)28-13-18)9-20(11-21)29-5-7-34-8-6-29/h1-4,9-13,22H,5-8,14-15H2,(H2,26,27,28) FUMKWTBAGZSSPX-UHFFFAOYSA-N 580867 (3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1-yl)(4- fluorophenyl)methanone::US11492348, Compound 79 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 210 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580867&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403588 475726703 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224342 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CN(Cc2ccc(F)cc2)C1)N1CCOCC1 InChI=1S/C24H26FN5O3S/c25-20-3-1-17(2-4-20)14-29-15-23(16-29)34(31,32)22-10-18(19-12-27-24(26)28-13-19)9-21(11-22)30-5-7-33-8-6-30/h1-4,9-13,23H,5-8,14-16H2,(H2,26,27,28) GBPKKPHGCBUIDU-UHFFFAOYSA-N 580868 5-(3-((1-(4-fluorobenzyl)azetidin-3- yl)sulfonyl)-5-morpholinophenyl)pyrimidin- 2-amine::US11492348, Compound 80 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 660 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580868&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177465 475726704 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224343 NC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C18H22N6O4S/c19-17-21-8-13(9-22-17)12-5-14(23-1-3-28-4-2-23)7-15(6-12)29(26,27)16-10-24(11-16)18(20)25/h5-9,16H,1-4,10-11H2,(H2,20,25)(H2,19,21,22) DQCCJKOIQDDDJX-UHFFFAOYSA-N 580869 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidine-1- carboxamide::US11492348, Compound 81 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 62.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580869&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177464 475726705 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224344 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CCc1ccc(F)cc1)N1CCOCC1 InChI=1S/C22H23FN4O3S/c23-19-3-1-16(2-4-19)5-10-31(28,29)21-12-17(18-14-25-22(24)26-15-18)11-20(13-21)27-6-8-30-9-7-27/h1-4,11-15H,5-10H2,(H2,24,25,26) KBLZPRZOOCVKTQ-UHFFFAOYSA-N 580870 5-(3-((4-fluorophenethyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 82 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 290 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580870&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177461 475726706 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224345 CC(=O)N1CCC(CC1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H27N5O4S/c1-15(27)25-4-2-19(3-5-25)31(28,29)20-11-16(17-13-23-21(22)24-14-17)10-18(12-20)26-6-8-30-9-7-26/h10-14,19H,2-9H2,1H3,(H2,22,23,24) LAKDHMSJDPGPMD-UHFFFAOYSA-N 580871 1-(4-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)piperidin-1- yl)ethan-1-one::US11492348, Compound 83 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 340 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580871&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177458 475726707 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224346 CC(C)(O)CNc1ccc(CS(=O)(=O)c2cc(cc(c2)-c2cnc(N)nc2)N2CCOCC2)cc1 InChI=1S/C25H31N5O4S/c1-25(2,31)17-29-21-5-3-18(4-6-21)16-35(32,33)23-12-19(20-14-27-24(26)28-15-20)11-22(13-23)30-7-9-34-10-8-30/h3-6,11-15,29,31H,7-10,16-17H2,1-2H3,(H2,26,27,28) JHTBZCUFQREXRY-UHFFFAOYSA-N 580872 1-((4-(((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)methyl)phenyl) amino)-2-methylpropan-2-ol::US11492348, Compound 84 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 600 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580872&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177462 475726708 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224347 C[C@H]1CC(C[C@@H](C)O1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H28N4O4S/c1-14-7-19(8-15(2)29-14)30(26,27)20-10-16(17-12-23-21(22)24-13-17)9-18(11-20)25-3-5-28-6-4-25/h9-15,19H,3-8H2,1-2H3,(H2,22,23,24)/t14-,15+,19? BUYGHGOQQLBVAA-RTHVDDQRSA-N 580873 5-(3-(((2R,6S)-2,6-dimethyltetrahydro-2H- pyran-4-yl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 85 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580873&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403555 475726709 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224348 CC(C)(C)C(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H29N5O4S/c1-22(2,3)20(28)27-13-19(14-27)32(29,30)18-9-15(16-11-24-21(23)25-12-16)8-17(10-18)26-4-6-31-7-5-26/h8-12,19H,4-7,13-14H2,1-3H3,(H2,23,24,25) LMMZIHFTTNPANU-UHFFFAOYSA-N 580874 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1-yl)- 2,2-dimethylpropan-1-one::US11492348, Compound 86 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 580 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580874&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177471 475726710 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224349 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C(F)(F)c1ccccc1)N1CCOCC1 InChI=1S/C21H20F2N4O3S/c22-21(23,17-4-2-1-3-5-17)31(28,29)19-11-15(16-13-25-20(24)26-14-16)10-18(12-19)27-6-8-30-9-7-27/h1-5,10-14H,6-9H2,(H2,24,25,26) LAYSHJBZMVAZOG-UHFFFAOYSA-N 580875 5-(3-((difluoro(phenyl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 87 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 210 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580875&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173028 475726711 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224350 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCC(F)(F)CC1)N1CCOCC1 InChI=1S/C20H24F2N4O3S/c21-20(22)3-1-17(2-4-20)30(27,28)18-10-14(15-12-24-19(23)25-13-15)9-16(11-18)26-5-7-29-8-6-26/h9-13,17H,1-8H2,(H2,23,24,25) JIVNHRQMFVKICN-UHFFFAOYSA-N 580876 5-(3-((4,4-difluorocyclohexyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 88 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 530 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580876&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177459 475726712 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224351 CC(C)N1CCC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H29N5O3S/c1-15(2)26-4-3-19(14-26)30(27,28)20-10-16(17-12-23-21(22)24-13-17)9-18(11-20)25-5-7-29-8-6-25/h9-13,15,19H,3-8,14H2,1-2H3,(H2,22,23,24) DRXVDQVBSCKALN-UHFFFAOYSA-N 580877 5-(3-((1-isopropylpyrrolidin-3-yl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine hydrochloride::US11492348, Compound 89 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2500 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580877&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403597 475726713 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224352 CC(C)N1CCC(CC1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H31N5O3S/c1-16(2)26-5-3-20(4-6-26)31(28,29)21-12-17(18-14-24-22(23)25-15-18)11-19(13-21)27-7-9-30-10-8-27/h11-16,20H,3-10H2,1-2H3,(H2,23,24,25) YWBOOFIYFHDXJW-UHFFFAOYSA-N 580878 5-(3-((1-isopropylpiperidin-4-yl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 90 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 7220 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580878&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177463 475726714 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224353 CC(=O)N1CCC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H25N5O4S/c1-14(26)25-3-2-18(13-25)30(27,28)19-9-15(16-11-22-20(21)23-12-16)8-17(10-19)24-4-6-29-7-5-24/h8-12,18H,2-7,13H2,1H3,(H2,21,22,23) YMNYQOBKIRPWSR-UHFFFAOYSA-N 580879 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)pyrrolidin-1- yl)ethan-1-one::US11492348, Compound 91 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 180 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580879&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177460 475726715 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224354 CC(C)(C)NC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H30N6O4S/c1-22(2,3)26-21(29)28-13-19(14-28)33(30,31)18-9-15(16-11-24-20(23)25-12-16)8-17(10-18)27-4-6-32-7-5-27/h8-12,19H,4-7,13-14H2,1-3H3,(H,26,29)(H2,23,24,25) LKWHZSGIFUMCLX-UHFFFAOYSA-N 580880 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N-(tert- butyl)azetidine-1-carboxamide::US11492348, Compound 92 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 150 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580880&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403551 475726716 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224355 CCNC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H26N6O4S/c1-2-22-20(27)26-12-18(13-26)31(28,29)17-8-14(15-10-23-19(21)24-11-15)7-16(9-17)25-3-5-30-6-4-25/h7-11,18H,2-6,12-13H2,1H3,(H,22,27)(H2,21,23,24) RBTWNXQTOCPFLO-UHFFFAOYSA-N 580881 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N- ethylazetidine-1-carboxamide::US11492348, Compound 93 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 88.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580881&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146175459 475726717 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224356 COCNC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H26N6O5S/c1-30-13-24-20(27)26-11-18(12-26)32(28,29)17-7-14(15-9-22-19(21)23-10-15)6-16(8-17)25-2-4-31-5-3-25/h6-10,18H,2-5,11-13H2,1H3,(H,24,27)(H2,21,22,23) ADHPKXSCGCUVNC-UHFFFAOYSA-N 580882 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N- (methoxymethyl)azetidine-1-carboxamide::US11492348, Compound 94 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 110 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580882&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403584 475726718 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224357 CN(C)C(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H26N6O4S/c1-24(2)20(27)26-12-18(13-26)31(28,29)17-8-14(15-10-22-19(21)23-11-15)7-16(9-17)25-3-5-30-6-4-25/h7-11,18H,3-6,12-13H2,1-2H3,(H2,21,22,23) HHRCZUVDMACSEU-UHFFFAOYSA-N 580883 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N,N- dimethylazetidine-1-carboxamide::US11492348, Compound 95 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 120 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580883&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403576 475726719 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224358 Nc1ccc(nn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1F)N1CCOCC1 InChI=1S/C21H20F2N4O3S/c22-16-2-1-14(19(23)11-16)13-31(28,29)18-10-15(20-3-4-21(24)26-25-20)9-17(12-18)27-5-7-30-8-6-27/h1-4,9-12H,5-8,13H2,(H2,24,26) PTCBOMFJHXSNJC-UHFFFAOYSA-N 580884 6-(3-((2,4-difluorobenzyl)sulfonyl)-5- morpholinophenyl)pyridazin-3-amine::US11492348, Compound 96 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1400 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580884&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177526 475726720 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224359 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccncc1)N1CCOCC1 InChI=1S/C20H21N5O3S/c21-20-23-12-17(13-24-20)16-9-18(25-5-7-28-8-6-25)11-19(10-16)29(26,27)14-15-1-3-22-4-2-15/h1-4,9-13H,5-8,14H2,(H2,21,23,24) CODANOSHVFIHQI-UHFFFAOYSA-N 580885 5-(3-morpholino-5-((pyridin-4- ylmethyl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 97 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 510 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580885&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177525 475726721 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224360 Nc1ccc(nc1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1F)N1CCOCC1 InChI=1S/C22H21F2N3O3S/c23-17-2-1-15(21(24)11-17)14-31(28,29)20-10-16(22-4-3-18(25)13-26-22)9-19(12-20)27-5-7-30-8-6-27/h1-4,9-13H,5-8,14,25H2 SLUQVGZMZFYNHI-UHFFFAOYSA-N 580886 -(3-((2,4-difluorobenzyl)sulfonyl)-5- morpholinophenyl)pyridin-3-amine::US11492348, Compound 98 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 12000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580886&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177532 475726722 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224361 Cc1cc(N)nnc1-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1F)N1CCOCC1 InChI=1S/C22H22F2N4O3S/c1-14-8-21(25)26-27-22(14)16-9-18(28-4-6-31-7-5-28)12-19(10-16)32(29,30)13-15-2-3-17(23)11-20(15)24/h2-3,8-12H,4-7,13H2,1H3,(H2,25,26) UKCVTZAPPCNGLE-UHFFFAOYSA-N 580887 6-(3-((2,4-difluorobenzyl)sulfonyl)-5- morpholinophenyl)-5-methylpyridazin-3- amine::US11492348, Compound 99 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 4300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580887&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177527 475726723 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224362 Nc1ncc(cc1C(F)(F)F)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C20H22F3N3O4S/c21-20(22,23)18-9-14(11-25-19(18)24)13-7-15(26-2-5-29-6-3-26)10-17(8-13)31(27,28)16-1-4-30-12-16/h7-11,16H,1-6,12H2,(H2,24,25)/t16-/m1/s1 MTRSYZORTNDHQH-MRXNPFEDSA-N 580888 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-3- (trifluoromethyl)pyridin-2-amine::US11492348, Compound 100 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1600 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580888&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177401 475726724 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224363 Nc1ccc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C19H23N3O4S/c20-19-2-1-14(12-21-19)15-9-16(22-4-7-25-8-5-22)11-18(10-15)27(23,24)17-3-6-26-13-17/h1-2,9-12,17H,3-8,13H2,(H2,20,21)/t17-/m1/s1 HUTDGWMBXAJTFX-QGZVFWFLSA-N 580889 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 101 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 880 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580889&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177400 475726725 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224364 O=C(C1CC1)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(NC2CC2)nc1)N1CCOCC1 InChI=1S/C24H29N5O4S/c30-23(16-1-2-16)29-14-22(15-29)34(31,32)21-10-17(9-20(11-21)28-5-7-33-8-6-28)18-12-25-24(26-13-18)27-19-3-4-19/h9-13,16,19,22H,1-8,14-15H2,(H,25,26,27) PVGCVDXYYMLKTI-UHFFFAOYSA-N 580890 US11492348, Compound 102::cyclopropyl(3-((3-(2- (cyclopropylamino)pyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1- yl)methanone Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 540 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580890&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177402 475726726 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224365 O=S(=O)(C1CCOC1)c1cc(cc(c1)-c1cnc(NC2CC2)nc1)N1CCOCC1 InChI=1S/C21H26N4O4S/c26-30(27,19-3-6-29-14-19)20-10-15(9-18(11-20)25-4-7-28-8-5-25)16-12-22-21(23-13-16)24-17-1-2-17/h9-13,17,19H,1-8,14H2,(H,22,23,24) RUNUGPBGQHZGLN-UHFFFAOYSA-N 580891 N-cyclopropyl-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 103 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 680 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580891&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177394 475726727 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224366 O=S(=O)(Cc1ccccc1)c1cc(cc(c1)-c1cnc(NC2CC2)nc1)N1CCOCC1 InChI=1S/C24H26N4O3S/c29-32(30,17-18-4-2-1-3-5-18)23-13-19(12-22(14-23)28-8-10-31-11-9-28)20-15-25-24(26-16-20)27-21-6-7-21/h1-5,12-16,21H,6-11,17H2,(H,25,26,27) FZLMDCZTQHDCBA-UHFFFAOYSA-N 580892 5-(3-(benzylsulfonyl)-5-morpholinophenyl)- N-cyclopropylpyrimidin-2-amine::US11492348, Compound 104 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580892&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177392 475726728 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224367 Nc1ccc(-c2cc(cc(c2)S(=O)(=O)[C@@H]2CCOC2)N2CCOCC2)c(n1)C(F)(F)F InChI=1S/C20H22F3N3O4S/c21-20(22,23)19-17(1-2-18(24)25-19)13-9-14(26-4-7-29-8-5-26)11-16(10-13)31(27,28)15-3-6-30-12-15/h1-2,9-11,15H,3-8,12H2,(H2,24,25)/t15-/m1/s1 YTIHKVBZOUODLS-OAHLLOKOSA-N 580893 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-6- (trifluoromethyl)pyridin-2-amine::US11492348, Compound 105 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1700 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580893&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177403 475726729 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224368 Nc1cc(F)c(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C19H22FN3O4S/c20-18-10-19(21)22-11-17(18)13-7-14(23-2-5-26-6-3-23)9-16(8-13)28(24,25)15-1-4-27-12-15/h7-11,15H,1-6,12H2,(H2,21,22)/t15-/m1/s1 WTSDUVPALLLEIC-OAHLLOKOSA-N 580894 (R)-4-fluoro-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 106 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 100.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580894&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177393 475726730 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224369 Nc1cc(Cl)c(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C19H22ClN3O4S/c20-18-10-19(21)22-11-17(18)13-7-14(23-2-5-26-6-3-23)9-16(8-13)28(24,25)15-1-4-27-12-15/h7-11,15H,1-6,12H2,(H2,21,22)/t15-/m1/s1 DREGPUYHKUGXIX-OAHLLOKOSA-N 580895 (R)-4-chloro-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 107 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 67.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580895&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177404 475726731 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224370 CNc1ccc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C20H25N3O4S/c1-21-20-3-2-15(13-22-20)16-10-17(23-5-8-26-9-6-23)12-19(11-16)28(24,25)18-4-7-27-14-18/h2-3,10-13,18H,4-9,14H2,1H3,(H,21,22)/t18-/m1/s1 NEBGGJXVTCYVRW-GOSISDBHSA-N 580896 (R)-N-methyl-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 108 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 690 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580896&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177405 475726732 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224371 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1coc2ccccc12)N1CCOCC1 InChI=1S/C22H20N4O4S/c23-22-24-12-16(13-25-22)15-9-17(26-5-7-29-8-6-26)11-18(10-15)31(27,28)21-14-30-20-4-2-1-3-19(20)21/h1-4,9-14H,5-8H2,(H2,23,24,25) VHKNCLVJHQMXJP-UHFFFAOYSA-N 580897 5-(3-(benzofuran-3-ylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 109 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1200 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580897&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173222 475726733 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224372 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc2ccoc12)N1CCOCC1 InChI=1S/C22H20N4O4S/c23-22-24-13-17(14-25-22)16-10-18(26-5-8-29-9-6-26)12-19(11-16)31(27,28)20-3-1-2-15-4-7-30-21(15)20/h1-4,7,10-14H,5-6,8-9H2,(H2,23,24,25) XHNOMXWHDQWEPR-UHFFFAOYSA-N 580898 5-(3-(benzofuran-7-ylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 110 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 400 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580898&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403578 475726734 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224373 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc2CCOc12)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-13-17(14-25-22)16-10-18(26-5-8-29-9-6-26)12-19(11-16)31(27,28)20-3-1-2-15-4-7-30-21(15)20/h1-3,10-14H,4-9H2,(H2,23,24,25) CHMWZOJYOCHQQM-UHFFFAOYSA-N 580899 5-(3-((2,3-dihydrobenzofuran-7-yl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 111 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 380 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580899&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403574 475726735 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224374 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc2ccoc2c1)N1CCOCC1 InChI=1S/C22H20N4O4S/c23-22-24-13-17(14-25-22)16-9-18(26-4-7-29-8-5-26)11-20(10-16)31(27,28)19-2-1-15-3-6-30-21(15)12-19/h1-3,6,9-14H,4-5,7-8H2,(H2,23,24,25) DXYJIZGMAVBSRD-UHFFFAOYSA-N 580900 5-(3-(benzofuran-6-ylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 112 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580900&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177406 475726736 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224375 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)\C=C\c1ccccc1O)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-14-18(15-25-22)17-11-19(26-6-8-30-9-7-26)13-20(12-17)31(28,29)10-5-16-3-1-2-4-21(16)27/h1-5,10-15,27H,6-9H2,(H2,23,24,25)/b10-5+ VWSZMUAJTFRSBT-BJMVGYQFSA-N 580901 (E)-2-(2-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)vinyl)phenol::US11492348, Compound 113 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580901&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173605 475726737 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224376 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1c[nH]c2ccccc12)N1CCOCC1 InChI=1S/C22H21N5O3S/c23-22-25-12-16(13-26-22)15-9-17(27-5-7-30-8-6-27)11-18(10-15)31(28,29)21-14-24-20-4-2-1-3-19(20)21/h1-4,9-14,24H,5-8H2,(H2,23,25,26) PTXPJFUWHPHQMQ-UHFFFAOYSA-N 580902 5-(3-((1H-indol-3-yl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 114 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2400 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580902&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177497 475726738 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224377 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)c1ccccc1 InChI=1S/C19H19N5O3S/c20-19-21-12-14(13-22-19)17-10-16(28(25,26)15-4-2-1-3-5-15)11-18(23-17)24-6-8-27-9-7-24/h1-5,10-13H,6-9H2,(H2,20,21,22) JKWJJSBYSROHTC-UHFFFAOYSA-N 580903 5-(6-morpholino-4-(phenylsulfonyl)pyridin- 2-yl)pyrimidin-2-amine::US11492348, Compound 115 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 66.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580903&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173051 475726739 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224378 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc2CCOc2c1)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-13-17(14-25-22)16-9-18(26-4-7-29-8-5-26)11-20(10-16)31(27,28)19-2-1-15-3-6-30-21(15)12-19/h1-2,9-14H,3-8H2,(H2,23,24,25) XRAYWWJSERJSCZ-UHFFFAOYSA-N 580904 5-(3-((2,3-dihydrobenzofuran-6-yl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 116 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 2300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580904&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177498 475726740 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224379 Nc1ncc(cn1)-c1cc(cc(n1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C19H19N5O3S/c20-19-21-12-14(13-22-19)17-10-15(24-6-8-27-9-7-24)11-18(23-17)28(25,26)16-4-2-1-3-5-16/h1-5,10-13H,6-9H2,(H2,20,21,22) ICLOQJROEDOSQW-UHFFFAOYSA-N 580905 5-(4-morpholino-6-(phenylsulfonyl)pyridin- 2-yl)pyrimidin-2-amine::US11492348, Compound 117 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 3300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580905&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173118 475726741 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224380 Nc1ncc(cn1)-c1cc(nc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C19H19N5O3S/c20-19-21-12-15(13-22-19)14-10-17(24-6-8-27-9-7-24)23-18(11-14)28(25,26)16-4-2-1-3-5-16/h1-5,10-13H,6-9H2,(H2,20,21,22) JWQMKOMDJBLFAT-UHFFFAOYSA-N 580906 5-(2-morpholino-6-(phenylsulfonyl)pyridin- 4-yl)pyrimidin-2-amine::US11492348, Compound 118 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 880 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580906&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173006 475726742 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224381 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1COc2ccccc12)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-12-16(13-25-22)15-9-17(26-5-7-29-8-6-26)11-18(10-15)31(27,28)21-14-30-20-4-2-1-3-19(20)21/h1-4,9-13,21H,5-8,14H2,(H2,23,24,25) GOTAIGHGVOKIIG-UHFFFAOYSA-N 580907 5-(3-((2,3-dihydrobenzofuran-3-yl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 119 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 110 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580907&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173219 475726743 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224382 Nc1ncc(cn1)-c1cc(Oc2ccccc2)cc(n1)N1CCOCC1 InChI=1S/C19H19N5O2/c20-19-21-12-14(13-22-19)17-10-16(26-15-4-2-1-3-5-15)11-18(23-17)24-6-8-25-9-7-24/h1-5,10-13H,6-9H2,(H2,20,21,22) NORCBTIZLLLLCH-UHFFFAOYSA-N 580908 5-(6-morpholino-4-phenoxypyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 120 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 91.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580908&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173263 475726744 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224383 Cc1nc(N)ncc1-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C19H24N4O4S/c1-13-18(11-21-19(20)22-13)14-8-15(23-3-6-26-7-4-23)10-17(9-14)28(24,25)16-2-5-27-12-16/h8-11,16H,2-7,12H2,1H3,(H2,20,21,22)/t16-/m1/s1 JNDPXEIBNOLUHV-MRXNPFEDSA-N 580909 (R)-4-methyl-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 121 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 840 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580909&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177466 475726745 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224384 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)c1ccccc1 InChI=1S/C20H19N5O2/c21-20-22-12-16(13-23-20)17-10-15(19(26)14-4-2-1-3-5-14)11-18(24-17)25-6-8-27-9-7-25/h1-5,10-13H,6-9H2,(H2,21,22,23) LZKXBBBGUGTFQS-UHFFFAOYSA-N 580910 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(phenyl)methanone::US11492348, Compound 122 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 37.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580910&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173102 475726746 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224385 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(F)(F)c1ccccc1 InChI=1S/C20H19F2N5O/c21-20(22,15-4-2-1-3-5-15)16-10-17(14-12-24-19(23)25-13-14)26-18(11-16)27-6-8-28-9-7-27/h1-5,10-13H,6-9H2,(H2,23,24,25) VYJVZMADYMHXLJ-UHFFFAOYSA-N 580911 5-(4-(difluoro(phenyl)methyl)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 123 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 46.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580911&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173013 475726747 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224386 Nc1ncc(cn1)-c1cc(Cc2ccccc2)cc(n1)N1CCOCC1 InChI=1S/C20H21N5O/c21-20-22-13-17(14-23-20)18-11-16(10-15-4-2-1-3-5-15)12-19(24-18)25-6-8-26-9-7-25/h1-5,11-14H,6-10H2,(H2,21,22,23) BIBKDEWJEDPFAP-UHFFFAOYSA-N 580912 5-(4-benzyl-6-morpholinopyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 124 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 120 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580912&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177467 475726748 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224387 CC(c1ccccc1)c1cc(nc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H23N5O/c1-15(16-5-3-2-4-6-16)17-11-19(18-13-23-21(22)24-14-18)25-20(12-17)26-7-9-27-10-8-26/h2-6,11-15H,7-10H2,1H3,(H2,22,23,24) BOWLTCSRJMCFBE-UHFFFAOYSA-N 580913 5-(6-morpholino-4-(1-phenylethyl)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 125 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 210 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580913&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173030 475726749 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224388 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=C)c1ccccc1 InChI=1S/C21H21N5O/c1-15(16-5-3-2-4-6-16)17-11-19(18-13-23-21(22)24-14-18)25-20(12-17)26-7-9-27-10-8-26/h2-6,11-14H,1,7-10H2,(H2,22,23,24) ISNDHCBLFHJBMJ-UHFFFAOYSA-N 580914 5-(6-morpholino-4-(1-phenylvinyl)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 126 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 270 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580914&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173177 475726750 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224389 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C1(CC1)c1ccccc1 InChI=1S/C22H23N5O/c23-21-24-14-16(15-25-21)19-12-18(13-20(26-19)27-8-10-28-11-9-27)22(6-7-22)17-4-2-1-3-5-17/h1-5,12-15H,6-11H2,(H2,23,24,25) YUAITLJOHKMDAE-UHFFFAOYSA-N 580915 5-(6-morpholino-4-(1- phenylcyclopropyl)pyridin-2-yl)pyrimidin-2- amine::US11492348, Compound 127 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 56.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580915&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173125 475726751 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224390 Nc1ncc(cn1)-c1cc(Oc2ccc(Cl)c(c2)C(F)(F)F)cc(n1)N1CCOCC1 InChI=1S/C20H17ClF3N5O2/c21-16-2-1-13(7-15(16)20(22,23)24)31-14-8-17(12-10-26-19(25)27-11-12)28-18(9-14)29-3-5-30-6-4-29/h1-2,7-11H,3-6H2,(H2,25,26,27) UCCMLSZWESYKCS-UHFFFAOYSA-N 580916 5-(4-(4-chloro-3-(trifluoromethyl)phenoxy)- 6-morpholinopyridin-2-yl)pyrimidin-2- amine::US11492348, Compound 128::US11492348, Compound 132 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1220 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580916&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177528 475726752 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224391 Nc1ncc(cn1)-c1cc(OC2CN(C2)C(=O)C2CC2)cc(n1)N1CCOCC1 InChI=1S/C20H24N6O3/c21-20-22-9-14(10-23-20)17-7-15(8-18(24-17)25-3-5-28-6-4-25)29-16-11-26(12-16)19(27)13-1-2-13/h7-10,13,16H,1-6,11-12H2,(H2,21,22,23) ZUOOZRKTIWVPFW-UHFFFAOYSA-N 580917 (3-((2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)oxy)azetidin-1- yl)(cyclopropyl)methanone::US11492348, Compound 129 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 34.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580917&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173017 475726753 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224392 Nc1ncc(cn1)-c1cc(OC2CCOC2)cc(n1)N1CCOCC1 InChI=1S/C17H21N5O3/c18-17-19-9-12(10-20-17)15-7-14(25-13-1-4-24-11-13)8-16(21-15)22-2-5-23-6-3-22/h7-10,13H,1-6,11H2,(H2,18,19,20) BXETYAXZBHMEMY-UHFFFAOYSA-N 580918 5-(6-morpholino-4-((tetrahydrofuran-3- yl)oxy)pyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 130 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 23.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580918&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177529 475726754 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224393 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)C1CCOCC1 InChI=1S/C19H23N5O3/c20-19-21-11-15(12-22-19)16-9-14(18(25)13-1-5-26-6-2-13)10-17(23-16)24-3-7-27-8-4-24/h9-13H,1-8H2,(H2,20,21,22) URYLXGQUXXMCGL-UHFFFAOYSA-N 580919 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(tetrahydro-2H- pyran-4-yl)methanone::US11492348, Compound 131 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 23.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580919&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177533 475726755 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224394 Nc1ncc(cn1)-c1cc(Oc2ccc(Cl)c(c2)C(F)(F)F)cc(n1)N1CCOCC1 InChI=1S/C20H17ClF3N5O2/c21-16-2-1-13(7-15(16)20(22,23)24)31-14-8-17(12-10-26-19(25)27-11-12)28-18(9-14)29-3-5-30-6-4-29/h1-2,7-11H,3-6H2,(H2,25,26,27) UCCMLSZWESYKCS-UHFFFAOYSA-N 580916 5-(4-(4-chloro-3-(trifluoromethyl)phenoxy)- 6-morpholinopyridin-2-yl)pyrimidin-2- amine::US11492348, Compound 128::US11492348, Compound 132 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1210 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580916&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177528 475726752 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224395 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(F)(F)C1CCOCC1 InChI=1S/C19H23F2N5O2/c20-19(21,14-1-5-27-6-2-14)15-9-16(13-11-23-18(22)24-12-13)25-17(10-15)26-3-7-28-8-4-26/h9-12,14H,1-8H2,(H2,22,23,24) XFPYMWIXBOVFON-UHFFFAOYSA-N 580921 5-(4-(difluoro(tetrahydro-2H-pyran-4- yl)methyl)-6-morpholinopyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 133 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 12.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580921&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177531 475726756 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224396 Nc1ncc(cn1)-c1cc(Oc2ccccc2Cl)cc(n1)N1CCOCC1 InChI=1S/C19H18ClN5O2/c20-15-3-1-2-4-17(15)27-14-9-16(13-11-22-19(21)23-12-13)24-18(10-14)25-5-7-26-8-6-25/h1-4,9-12H,5-8H2,(H2,21,22,23) SEZCHLLNKIYQLL-UHFFFAOYSA-N 580922 5-(4-(2-chlorophenoxy)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 134 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 70.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580922&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177530 475726757 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224397 COc1ccccc1Oc1cc(nc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H21N5O3/c1-26-17-4-2-3-5-18(17)28-15-10-16(14-12-22-20(21)23-13-14)24-19(11-15)25-6-8-27-9-7-25/h2-5,10-13H,6-9H2,1H3,(H2,21,22,23) YHJAWWBUBRTVQJ-UHFFFAOYSA-N 580923 5-(4-(2-methoxyphenoxy)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 135 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 79.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580923&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177569 475726758 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224398 Nc1ncc(cn1)-c1cc(Oc2ccccc2OC(F)(F)F)cc(n1)N1CCOCC1 InChI=1S/C20H18F3N5O3/c21-20(22,23)31-17-4-2-1-3-16(17)30-14-9-15(13-11-25-19(24)26-12-13)27-18(10-14)28-5-7-29-8-6-28/h1-4,9-12H,5-8H2,(H2,24,25,26) KHIUCPUWDPSZOH-UHFFFAOYSA-N 580924 5-(6-morpholino-4-(2- (trifluoromethoxy)phenoxy)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 136 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 370 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580924&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403562 475726759 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224399 Cc1ccccc1Oc1cc(nc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H21N5O2/c1-14-4-2-3-5-18(14)27-16-10-17(15-12-22-20(21)23-13-15)24-19(11-16)25-6-8-26-9-7-25/h2-5,10-13H,6-9H2,1H3,(H2,21,22,23) STGMRFRVEBSQDM-UHFFFAOYSA-N 580925 5-(6-morpholino-4-(o-tolyloxy)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 137 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 75.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580925&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177566 475726760 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224400 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)c1ccccc1Cl InChI=1S/C20H18ClN5O2/c21-16-4-2-1-3-15(16)19(27)13-9-17(14-11-23-20(22)24-12-14)25-18(10-13)26-5-7-28-8-6-26/h1-4,9-12H,5-8H2,(H2,22,23,24) XZOPDDDJHRZAKW-UHFFFAOYSA-N 580926 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(2- chlorophenyl)methanone::US11492348, Compound 138 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 14.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580926&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177570 475726761 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224401 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)c1ccccc1Cl InChI=1S/C19H18ClN5O3S/c20-15-3-1-2-4-17(15)29(26,27)14-9-16(13-11-22-19(21)23-12-13)24-18(10-14)25-5-7-28-8-6-25/h1-4,9-12H,5-8H2,(H2,21,22,23) JTYJEIBZRLYYQC-UHFFFAOYSA-N 580927 5-(4-((2-chlorophenyl)sulfonyl)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 139 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 17.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580927&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403570 475726762 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224402 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)N1CCCc2ccccc12 InChI=1S/C22H24N6O/c23-22-24-14-17(15-25-22)19-12-18(13-21(26-19)27-8-10-29-11-9-27)28-7-3-5-16-4-1-2-6-20(16)28/h1-2,4,6,12-15H,3,5,7-11H2,(H2,23,24,25) WETSTVOERCRPHB-UHFFFAOYSA-N 580928 5-(4-(3,4-dihydroquinolin-1(2H)-yl)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 140 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 120 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580928&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177542 475726763 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224403 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C1CCOc2ccccc12 InChI=1S/C22H23N5O2/c23-22-24-13-16(14-25-22)19-11-15(12-21(26-19)27-6-9-28-10-7-27)17-5-8-29-20-4-2-1-3-18(17)20/h1-4,11-14,17H,5-10H2,(H2,23,24,25) OKBSPDKFQWHVEU-UHFFFAOYSA-N 580929 5-(4-(chroman-4-yl)-6-morpholinopyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 141 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 62.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580929&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177563 475726764 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224404 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)[C@H]1CCOC1 InChI=1S/C17H21N5O4S/c18-17-19-9-12(10-20-17)15-7-14(27(23,24)13-1-4-26-11-13)8-16(21-15)22-2-5-25-6-3-22/h7-10,13H,1-6,11H2,(H2,18,19,20)/t13-/m0/s1 XNGARQQVWZXOKC-ZDUSSCGKSA-N 580930 (S)-5-(6-morpholino-4-((tetrahydrofuran-3- yl)sulfonyl)pyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 142a Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 5.70 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580930&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173235 475726765 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224405 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)[C@@H]1CCOC1 InChI=1S/C17H21N5O4S/c18-17-19-9-12(10-20-17)15-7-14(27(23,24)13-1-4-26-11-13)8-16(21-15)22-2-5-25-6-3-22/h7-10,13H,1-6,11H2,(H2,18,19,20)/t13-/m1/s1 XNGARQQVWZXOKC-CYBMUJFWSA-N 580931 (R)-5-(6-morpholino-4-((tetrahydrofuran-3- yl)sulfonyl)pyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 142b Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 6.80 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580931&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177534 475726766 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224406 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)C1CCOc2ccccc12 InChI=1S/C22H23N5O4S/c23-22-24-13-15(14-25-22)18-11-16(12-21(26-18)27-6-9-30-10-7-27)32(28,29)20-5-8-31-19-4-2-1-3-17(19)20/h1-4,11-14,20H,5-10H2,(H2,23,24,25) ONIJZTXFVDGPGP-UHFFFAOYSA-N 580932 5-(4-(chroman-4-ylsulfonyl)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 143 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1.70 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580932&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146173541 475726767 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224407 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)[C@@H]1CCOc2ccccc12 InChI=1S/C22H23N5O4S/c23-22-24-13-15(14-25-22)18-11-16(12-21(26-18)27-6-9-30-10-7-27)32(28,29)20-5-8-31-19-4-2-1-3-17(19)20/h1-4,11-14,20H,5-10H2,(H2,23,24,25)/t20-/m1/s1 ONIJZTXFVDGPGP-HXUWFJFHSA-N 580933 US11492348, Compound (+)143 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 4.50 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580933&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 166594437 475726768 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224408 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)[C@@H]1CCOc2ccccc12 InChI=1S/C22H23N5O4S/c23-22-24-13-15(14-25-22)18-11-16(12-21(26-18)27-6-9-30-10-7-27)32(28,29)20-5-8-31-19-4-2-1-3-17(19)20/h1-4,11-14,20H,5-10H2,(H2,23,24,25)/t20-/m1/s1 ONIJZTXFVDGPGP-HXUWFJFHSA-N 580934 US11492348, Compound (-)143 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 1.000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580934&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 166594437 475726769 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224409 Nc1cc(c(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)c1ccccc1)C(F)(F)F InChI=1S/C21H19F3N4O3S/c22-21(23,24)17-12-19(25)26-13-16(17)18-10-15(32(29,30)14-4-2-1-3-5-14)11-20(27-18)28-6-8-31-9-7-28/h1-5,10-13H,6-9H2,(H2,25,26) QFYPUDAOZZAZDG-UHFFFAOYSA-N 580935 6-morpholino-4-(phenylsulfonyl)-4'- (trifluoromethyl)-[2,3'-bipyridin]-6'-amine::US11492348, Compound 144 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 390 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580935&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177536 475726770 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224410 CC(=O)Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)c1ccccc1 InChI=1S/C21H21N5O4S/c1-15(27)24-21-22-13-16(14-23-21)19-11-18(31(28,29)17-5-3-2-4-6-17)12-20(25-19)26-7-9-30-10-8-26/h2-6,11-14H,7-10H2,1H3,(H,22,23,24,27) QCVRIDAIEFLLDO-UHFFFAOYSA-N 580936 N-(5-(6-morpholino-4- (phenylsulfonyl)pyridin-2-yl)pyrimidin-2- yl)acetamide::US11492348, Compound 145 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 390 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580936&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403571 475726771 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224411 O=S(=O)(c1ccccc1)c1cc(nc(c1)-c1cnc(NC2CC2)nc1)N1CCOCC1 InChI=1S/C22H23N5O3S/c28-31(29,18-4-2-1-3-5-18)19-12-20(26-21(13-19)27-8-10-30-11-9-27)16-14-23-22(24-15-16)25-17-6-7-17/h1-5,12-15,17H,6-11H2,(H,23,24,25) XOHBIGVVKAHDSV-UHFFFAOYSA-N 580937 N-cyclopropyl-5-(6-morpholino-4- (phenylsulfonyl)pyridin-2-yl)pyrimidin-2- amine::US11492348, Compound 146 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 370 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580937&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 156403560 475726772 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224412 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)C1COc2ccccc12 InChI=1S/C21H21N5O4S/c22-21-23-11-14(12-24-21)17-9-15(10-20(25-17)26-5-7-29-8-6-26)31(27,28)19-13-30-18-4-2-1-3-16(18)19/h1-4,9-12,19H,5-8,13H2,(H2,22,23,24) DHSLXXOLRGCXSN-UHFFFAOYSA-N 580938 5-(4-((2,3-dihydrobenzofuran-3-yl)sulfonyl)- 6-morpholinopyridin-2-yl)pyrimidin-2- amine::US11492348, Compound 147 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 7.00 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580938&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177535 475726773 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224413 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)C1CCOCC1 InChI=1S/C18H23N5O4S/c19-18-20-11-13(12-21-18)16-9-15(28(24,25)14-1-5-26-6-2-14)10-17(22-16)23-3-7-27-8-4-23/h9-12,14H,1-8H2,(H2,19,20,21) ICOKHIMJIZTIGD-UHFFFAOYSA-N 580939 5-(6-morpholino-4-((tetrahydro-2H-pyran-4- yl)sulfonyl)pyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 148 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 13.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580939&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177499 475726774 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224414 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)C1CCOC1 InChI=1S/C18H21N5O3/c19-18-20-9-14(10-21-18)15-7-13(17(24)12-1-4-26-11-12)8-16(22-15)23-2-5-25-6-3-23/h7-10,12H,1-6,11H2,(H2,19,20,21) SNQRXUSNMXGWPK-UHFFFAOYSA-N 580940 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(tetrahydrofuran-3- yl)methanone::US11492348, Compound 149 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 14.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580940&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177502 475726775 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224415 CC1CN(CC(C)O1)c1cc(cc(n1)-c1cnc(N)nc1)S(=O)(=O)c1ccccc1 InChI=1S/C21H23N5O3S/c1-14-12-26(13-15(2)29-14)20-9-18(30(27,28)17-6-4-3-5-7-17)8-19(25-20)16-10-23-21(22)24-11-16/h3-11,14-15H,12-13H2,1-2H3,(H2,22,23,24) AVANBXCYTAFIST-UHFFFAOYSA-N 580941 5-(6-(2,6-dimethylmorpholino)-4- (phenylsulfonyl)pyridin-2-yl)pyrimidin-2- amine::US11492348, Compound 150 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 450 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580941&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177500 475726776 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224416 Nc1ncc(cn1)-c1cc(cc(n1)N1CC2CCC(C1)O2)S(=O)(=O)c1ccccc1 InChI=1S/C21H21N5O3S/c22-21-23-10-14(11-24-21)19-8-18(30(27,28)17-4-2-1-3-5-17)9-20(25-19)26-12-15-6-7-16(13-26)29-15/h1-5,8-11,15-16H,6-7,12-13H2,(H2,22,23,24) RKHJINDAHDQTJA-UHFFFAOYSA-N 580942 5-(6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)- 4-(phenylsulfonyl)pyridin-2-yl)pyrimidin-2- amine::US11492348, Compound 151 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens 830 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1622&target=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580942&enzyme=Phosphatidylinositol+4%2C5-bisphosphate+3-kinase+catalytic+subunit+alpha+isoform&column=ki&startPg=0&Increment=50&submit=Search 146177501 475726777 1 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN 2ENQ,2RD0,2V1Y,3ZIM,4L1B,4L23,4L2Y,4OVU,4OVV,4TUU,4TV3,4YKN,5DXH,5DXT,5SW8,5SWG,5SWO,5SWP,5SWR,5SWT,5SX8,5SX9,5SXA,5SXB,5SXC,5SXD,5SXE,5SXF,5SXI,5SXJ,5SXK,5UBR,5XGH,5XGI,5XGJ,6GVF,6GVG,6GVH,6GVI,6NCT,6OAC,6PYS,6VO7,7JIU,7K6M,7K6N,7K6O,7K71,7MLK,7MYN,7MYO,7R9V,7R9Y,8BFU,8BFV,8DCP,8DCX,8DD4,8DD8 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform PK3CA_HUMAN P42336 Q14CW1 Q99762 1224417 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C20H20N4O3S/c21-20-22-13-16(14-23-20)15-10-17(24-6-8-27-9-7-24)12-19(11-15)28(25,26)18-4-2-1-3-5-18/h1-5,10-14H,6-9H2,(H2,21,22,23) CQHLTHQSLFOTEX-UHFFFAOYSA-N 580789 5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 1 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 7520 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580789&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173115 475726625 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224418 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C20H20N4O3S/c21-20-22-13-16(14-23-20)15-10-17(24-6-8-27-9-7-24)12-19(11-15)28(25,26)18-4-2-1-3-5-18/h1-5,10-14H,6-9H2,(H2,21,22,23) CQHLTHQSLFOTEX-UHFFFAOYSA-N 580789 5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 1 Serine/threonine-protein kinase mTOR Homo sapiens 2000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580789&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173115 475726625 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224419 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(F)cc1)N1CCOCC1 InChI=1S/C20H19FN4O3S/c21-16-1-3-18(4-2-16)29(26,27)19-10-14(15-12-23-20(22)24-13-15)9-17(11-19)25-5-7-28-8-6-25/h1-4,9-13H,5-8H2,(H2,22,23,24) LISIKGZNDKCXNH-UHFFFAOYSA-N 580796 5-(3-((4-fluorophenyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 8 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 7620 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580796&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403593 475726632 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224420 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(F)cc1)N1CCOCC1 InChI=1S/C20H19FN4O3S/c21-16-1-3-18(4-2-16)29(26,27)19-10-14(15-12-23-20(22)24-13-15)9-17(11-19)25-5-7-28-8-6-25/h1-4,9-13H,5-8H2,(H2,22,23,24) LISIKGZNDKCXNH-UHFFFAOYSA-N 580796 5-(3-((4-fluorophenyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 8 Serine/threonine-protein kinase mTOR Homo sapiens 830 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580796&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403593 475726632 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224421 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(cc1)C#N)N1CCOCC1 InChI=1S/C21H19N5O3S/c22-12-15-1-3-19(4-2-15)30(27,28)20-10-16(17-13-24-21(23)25-14-17)9-18(11-20)26-5-7-29-8-6-26/h1-4,9-11,13-14H,5-8H2,(H2,23,24,25) PQJFFUOVDUCZMA-UHFFFAOYSA-N 580798 4-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 10 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 30700 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580798&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403543 475726634 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224422 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(cc1)C#N)N1CCOCC1 InChI=1S/C21H19N5O3S/c22-12-15-1-3-19(4-2-15)30(27,28)20-10-16(17-13-24-21(23)25-14-17)9-18(11-20)26-5-7-29-8-6-26/h1-4,9-11,13-14H,5-8H2,(H2,23,24,25) PQJFFUOVDUCZMA-UHFFFAOYSA-N 580798 4-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 10 Serine/threonine-protein kinase mTOR Homo sapiens 640 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580798&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403543 475726634 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224423 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(F)c(Cl)c1)N1CCOCC1 InChI=1S/C20H18ClFN4O3S/c21-18-10-16(1-2-19(18)22)30(27,28)17-8-13(14-11-24-20(23)25-12-14)7-15(9-17)26-3-5-29-6-4-26/h1-2,7-12H,3-6H2,(H2,23,24,25) KCEIJUIZISZHPA-UHFFFAOYSA-N 580799 5-(3-((3-chloro-4-fluorophenyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 11 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 100000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580799&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403598 475726635 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224424 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(F)c(Cl)c1)N1CCOCC1 InChI=1S/C20H18ClFN4O3S/c21-18-10-16(1-2-19(18)22)30(27,28)17-8-13(14-11-24-20(23)25-12-14)7-15(9-17)26-3-5-29-6-4-26/h1-2,7-12H,3-6H2,(H2,23,24,25) KCEIJUIZISZHPA-UHFFFAOYSA-N 580799 5-(3-((3-chloro-4-fluorophenyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 11 Serine/threonine-protein kinase mTOR Homo sapiens 22000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580799&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403598 475726635 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224425 Cc1cnccc1-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H22N2O3S/c1-17-16-23-8-7-22(17)18-13-19(24-9-11-27-12-10-24)15-21(14-18)28(25,26)20-5-3-2-4-6-20/h2-8,13-16H,9-12H2,1H3 OCSCJTVVJRDXDP-UHFFFAOYSA-N 580800 4-(3-(3-methylpyridin-4-yl)-5- (phenylsulfonyl)phenyl)morpholine::US11492348, Compound 12 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 100000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580800&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177519 475726636 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224426 Cc1cnccc1-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H22N2O3S/c1-17-16-23-8-7-22(17)18-13-19(24-9-11-27-12-10-24)15-21(14-18)28(25,26)20-5-3-2-4-6-20/h2-8,13-16H,9-12H2,1H3 OCSCJTVVJRDXDP-UHFFFAOYSA-N 580800 4-(3-(3-methylpyridin-4-yl)-5- (phenylsulfonyl)phenyl)morpholine::US11492348, Compound 12 Serine/threonine-protein kinase mTOR Homo sapiens 100000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580800&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177519 475726636 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224427 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc(c1)C#N)N1CCOCC1 InChI=1S/C21H19N5O3S/c22-12-15-2-1-3-19(8-15)30(27,28)20-10-16(17-13-24-21(23)25-14-17)9-18(11-20)26-4-6-29-7-5-26/h1-3,8-11,13-14H,4-7H2,(H2,23,24,25) NOVSQOKURKTTHJ-UHFFFAOYSA-N 580801 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 13 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 28600 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580801&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403550 475726637 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224428 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc(c1)C#N)N1CCOCC1 InChI=1S/C21H19N5O3S/c22-12-15-2-1-3-19(8-15)30(27,28)20-10-16(17-13-24-21(23)25-14-17)9-18(11-20)26-4-6-29-7-5-26/h1-3,8-11,13-14H,4-7H2,(H2,23,24,25) NOVSQOKURKTTHJ-UHFFFAOYSA-N 580801 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 13 Serine/threonine-protein kinase mTOR Homo sapiens 10000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580801&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403550 475726637 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224429 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(OC(F)(F)F)cc1)N1CCOCC1 InChI=1S/C21H19F3N4O4S/c22-21(23,24)32-17-1-3-18(4-2-17)33(29,30)19-10-14(15-12-26-20(25)27-13-15)9-16(11-19)28-5-7-31-8-6-28/h1-4,9-13H,5-8H2,(H2,25,26,27) GNRZQAOZAOLONJ-UHFFFAOYSA-N 580803 5-(3-morpholino-5-((4- (trifluoromethoxy)phenyl)sulfonyl)phenyl) pyrimidin-2-amine::US11492348, Compound 15 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 100000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580803&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403591 475726639 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224430 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(OC(F)(F)F)cc1)N1CCOCC1 InChI=1S/C21H19F3N4O4S/c22-21(23,24)32-17-1-3-18(4-2-17)33(29,30)19-10-14(15-12-26-20(25)27-13-15)9-16(11-19)28-5-7-31-8-6-28/h1-4,9-13H,5-8H2,(H2,25,26,27) GNRZQAOZAOLONJ-UHFFFAOYSA-N 580803 5-(3-morpholino-5-((4- (trifluoromethoxy)phenyl)sulfonyl)phenyl) pyrimidin-2-amine::US11492348, Compound 15 Serine/threonine-protein kinase mTOR Homo sapiens 22000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580803&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403591 475726639 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224431 Nc1ncc(-c2cc(cc(c2)S(=O)(=O)c2ccc(cc2)C#N)N2CCOCC2)c(n1)C(F)(F)F InChI=1S/C22H18F3N5O3S/c23-22(24,25)20-19(13-28-21(27)29-20)15-9-16(30-5-7-33-8-6-30)11-18(10-15)34(31,32)17-3-1-14(12-26)2-4-17/h1-4,9-11,13H,5-8H2,(H2,27,28,29) UOIGQFPHLCWPGS-UHFFFAOYSA-N 580805 4-((3-(2-amino-4- (trifluoromethyl)pyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 17 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 100000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580805&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403592 475726641 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224432 Nc1ncc(-c2cc(cc(c2)S(=O)(=O)c2ccc(cc2)C#N)N2CCOCC2)c(n1)C(F)(F)F InChI=1S/C22H18F3N5O3S/c23-22(24,25)20-19(13-28-21(27)29-20)15-9-16(30-5-7-33-8-6-30)11-18(10-15)34(31,32)17-3-1-14(12-26)2-4-17/h1-4,9-11,13H,5-8H2,(H2,27,28,29) UOIGQFPHLCWPGS-UHFFFAOYSA-N 580805 4-((3-(2-amino-4- (trifluoromethyl)pyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 17 Serine/threonine-protein kinase mTOR Homo sapiens 100000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580805&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403592 475726641 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224433 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(cc1)C#N)N1CCOCC1)C(F)(F)F InChI=1S/C23H19F3N4O3S/c24-23(25,26)21-12-22(28)29-14-20(21)16-9-17(30-5-7-33-8-6-30)11-19(10-16)34(31,32)18-3-1-15(13-27)2-4-18/h1-4,9-12,14H,5-8H2,(H2,28,29) BIVPSVOHMHKNQJ-UHFFFAOYSA-N 580806 4-((3-(6-amino-4-(trifluoromethyl)pyridin-3- yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 18 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 100000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580806&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177520 475726642 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224434 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc(cc1)C#N)N1CCOCC1)C(F)(F)F InChI=1S/C23H19F3N4O3S/c24-23(25,26)21-12-22(28)29-14-20(21)16-9-17(30-5-7-33-8-6-30)11-19(10-16)34(31,32)18-3-1-15(13-27)2-4-18/h1-4,9-12,14H,5-8H2,(H2,28,29) BIVPSVOHMHKNQJ-UHFFFAOYSA-N 580806 4-((3-(6-amino-4-(trifluoromethyl)pyridin-3- yl)-5- morpholinophenyl)sulfonyl)benzonitrile::US11492348, Compound 18 Serine/threonine-protein kinase mTOR Homo sapiens 100000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580806&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177520 475726642 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224435 OCCNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H24N4O4S/c27-9-6-23-22-24-15-18(16-25-22)17-12-19(26-7-10-30-11-8-26)14-21(13-17)31(28,29)20-4-2-1-3-5-20/h1-5,12-16,27H,6-11H2,(H,23,24,25) UXVRSRKRBBLSJY-UHFFFAOYSA-N 580807 2-((5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2- yl)amino)ethan-1-ol::US11492348, Compound 19 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 37000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580807&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403556 475726643 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224436 OCCNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H24N4O4S/c27-9-6-23-22-24-15-18(16-25-22)17-12-19(26-7-10-30-11-8-26)14-21(13-17)31(28,29)20-4-2-1-3-5-20/h1-5,12-16,27H,6-11H2,(H,23,24,25) UXVRSRKRBBLSJY-UHFFFAOYSA-N 580807 2-((5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2- yl)amino)ethan-1-ol::US11492348, Compound 19 Serine/threonine-protein kinase mTOR Homo sapiens 16000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580807&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403556 475726643 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224437 O=S(=O)(c1ccccc1)c1cc(cc(c1)-c1cnc(NC2CC2)nc1)N1CCOCC1 InChI=1S/C23H24N4O3S/c28-31(29,21-4-2-1-3-5-21)22-13-17(12-20(14-22)27-8-10-30-11-9-27)18-15-24-23(25-16-18)26-19-6-7-19/h1-5,12-16,19H,6-11H2,(H,24,25,26) AVSDJUUZCZSIGH-UHFFFAOYSA-N 580808 N-cyclopropyl-5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 20 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 100000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580808&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403564 475726644 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224438 O=S(=O)(c1ccccc1)c1cc(cc(c1)-c1cnc(NC2CC2)nc1)N1CCOCC1 InChI=1S/C23H24N4O3S/c28-31(29,21-4-2-1-3-5-21)22-13-17(12-20(14-22)27-8-10-30-11-9-27)18-15-24-23(25-16-18)26-19-6-7-19/h1-5,12-16,19H,6-11H2,(H,24,25,26) AVSDJUUZCZSIGH-UHFFFAOYSA-N 580808 N-cyclopropyl-5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 20 Serine/threonine-protein kinase mTOR Homo sapiens 10000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580808&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403564 475726644 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224439 Cc1ccc(cc1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H22N4O3S/c1-15-2-4-19(5-3-15)29(26,27)20-11-16(17-13-23-21(22)24-14-17)10-18(12-20)25-6-8-28-9-7-25/h2-5,10-14H,6-9H2,1H3,(H2,22,23,24) KOGZQRMLAGNKRT-UHFFFAOYSA-N 580809 5-(3-morpholino-5-tosylphenyl)pyrimidin-2- amine::US11492348, Compound 21 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 37000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580809&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403563 475726645 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224440 Cc1ccc(cc1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H22N4O3S/c1-15-2-4-19(5-3-15)29(26,27)20-11-16(17-13-23-21(22)24-14-17)10-18(12-20)25-6-8-28-9-7-25/h2-5,10-14H,6-9H2,1H3,(H2,22,23,24) KOGZQRMLAGNKRT-UHFFFAOYSA-N 580809 5-(3-morpholino-5-tosylphenyl)pyrimidin-2- amine::US11492348, Compound 21 Serine/threonine-protein kinase mTOR Homo sapiens 9390 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580809&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403563 475726645 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224441 CC(=O)Nc1ccc(cc1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H23N5O4S/c1-15(28)26-18-2-4-20(5-3-18)32(29,30)21-11-16(17-13-24-22(23)25-14-17)10-19(12-21)27-6-8-31-9-7-27/h2-5,10-14H,6-9H2,1H3,(H,26,28)(H2,23,24,25) JVZHZEZJQFVOIZ-UHFFFAOYSA-N 580810 N-(4-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)phenyl)acetamide::US11492348, Compound 22 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 39000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580810&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403567 475726646 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224442 CC(=O)Nc1ccc(cc1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H23N5O4S/c1-15(28)26-18-2-4-20(5-3-18)32(29,30)21-11-16(17-13-24-22(23)25-14-17)10-19(12-21)27-6-8-31-9-7-27/h2-5,10-14H,6-9H2,1H3,(H,26,28)(H2,23,24,25) JVZHZEZJQFVOIZ-UHFFFAOYSA-N 580810 N-(4-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)phenyl)acetamide::US11492348, Compound 22 Serine/threonine-protein kinase mTOR Homo sapiens 8690 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580810&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403567 475726646 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224443 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1 InChI=1S/C21H22N4O3S/c22-21-23-13-18(14-24-21)17-10-19(25-6-8-28-9-7-25)12-20(11-17)29(26,27)15-16-4-2-1-3-5-16/h1-5,10-14H,6-9,15H2,(H2,22,23,24) AXSUJMFUIXJCLT-UHFFFAOYSA-N 580811 5-(3-(benzylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 23 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 8500 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580811&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403565 475726647 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224444 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1 InChI=1S/C21H22N4O3S/c22-21-23-13-18(14-24-21)17-10-19(25-6-8-28-9-7-25)12-20(11-17)29(26,27)15-16-4-2-1-3-5-16/h1-5,10-14H,6-9,15H2,(H2,22,23,24) AXSUJMFUIXJCLT-UHFFFAOYSA-N 580811 5-(3-(benzylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 23 Serine/threonine-protein kinase mTOR Homo sapiens 3000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580811&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403565 475726647 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224445 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1F)N1CCOCC1 InChI=1S/C21H20F2N4O3S/c22-17-2-1-14(20(23)9-17)13-31(28,29)19-8-15(16-11-25-21(24)26-12-16)7-18(10-19)27-3-5-30-6-4-27/h1-2,7-12H,3-6,13H2,(H2,24,25,26) BSWWWMIFNUFSMO-UHFFFAOYSA-N 580814 5-(3-((2,4-difluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 26 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 6200 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580814&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403542 475726650 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224446 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1F)N1CCOCC1 InChI=1S/C21H20F2N4O3S/c22-17-2-1-14(20(23)9-17)13-31(28,29)19-8-15(16-11-25-21(24)26-12-16)7-18(10-19)27-3-5-30-6-4-27/h1-2,7-12H,3-6,13H2,(H2,24,25,26) BSWWWMIFNUFSMO-UHFFFAOYSA-N 580814 5-(3-((2,4-difluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 26 Serine/threonine-protein kinase mTOR Homo sapiens 5300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580814&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403542 475726650 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224447 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1cccc(c1)C#N)N1CCOCC1 InChI=1S/C22H21N5O3S/c23-12-16-2-1-3-17(8-16)15-31(28,29)21-10-18(19-13-25-22(24)26-14-19)9-20(11-21)27-4-6-30-7-5-27/h1-3,8-11,13-14H,4-7,15H2,(H2,24,25,26) KEVLFKYIMJFLKZ-UHFFFAOYSA-N 580815 3-(((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)methyl) benzonitrile::US11492348, Compound 27 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 14000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580815&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403568 475726651 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224448 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1cccc(c1)C#N)N1CCOCC1 InChI=1S/C22H21N5O3S/c23-12-16-2-1-3-17(8-16)15-31(28,29)21-10-18(19-13-25-22(24)26-14-19)9-20(11-21)27-4-6-30-7-5-27/h1-3,8-11,13-14H,4-7,15H2,(H2,24,25,26) KEVLFKYIMJFLKZ-UHFFFAOYSA-N 580815 3-(((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)methyl) benzonitrile::US11492348, Compound 27 Serine/threonine-protein kinase mTOR Homo sapiens 11000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580815&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403568 475726651 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224449 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(CO)cc1)N1CCOCC1 InChI=1S/C22H24N4O4S/c23-22-24-12-19(13-25-22)18-9-20(26-5-7-30-8-6-26)11-21(10-18)31(28,29)15-17-3-1-16(14-27)2-4-17/h1-4,9-13,27H,5-8,14-15H2,(H2,23,24,25) HEXZJRXLBPGLGP-UHFFFAOYSA-N 580816 5-(3-((4-methoxybenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 28 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 13000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580816&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 158459048 475726652 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224450 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(CO)cc1)N1CCOCC1 InChI=1S/C22H24N4O4S/c23-22-24-12-19(13-25-22)18-9-20(26-5-7-30-8-6-26)11-21(10-18)31(28,29)15-17-3-1-16(14-27)2-4-17/h1-4,9-13,27H,5-8,14-15H2,(H2,23,24,25) HEXZJRXLBPGLGP-UHFFFAOYSA-N 580816 5-(3-((4-methoxybenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 28 Serine/threonine-protein kinase mTOR Homo sapiens 7900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580816&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 158459048 475726652 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224451 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C21H21FN4O3S/c22-18-3-1-15(2-4-18)14-30(27,28)20-10-16(17-12-24-21(23)25-13-17)9-19(11-20)26-5-7-29-8-6-26/h1-4,9-13H,5-8,14H2,(H2,23,24,25) DINYTTSGCRGAJR-UHFFFAOYSA-N 580817 5-(3-((4-fluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 29 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 10900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580817&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403541 475726653 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224452 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C21H21FN4O3S/c22-18-3-1-15(2-4-18)14-30(27,28)20-10-16(17-12-24-21(23)25-13-17)9-19(11-20)26-5-7-29-8-6-26/h1-4,9-13H,5-8,14H2,(H2,23,24,25) DINYTTSGCRGAJR-UHFFFAOYSA-N 580817 5-(3-((4-fluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 29 Serine/threonine-protein kinase mTOR Homo sapiens 10900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580817&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403541 475726653 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224453 CC(=O)Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H22N4O4S/c1-16(27)25-22-23-14-18(15-24-22)17-11-19(26-7-9-30-10-8-26)13-21(12-17)31(28,29)20-5-3-2-4-6-20/h2-6,11-15H,7-10H2,1H3,(H,23,24,25,27) UTJHTHZLECYYPO-UHFFFAOYSA-N 580818 N-(5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2- yl)acetamide::US11492348, Compound 30 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 18000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580818&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403547 475726654 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224454 CC(=O)Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C22H22N4O4S/c1-16(27)25-22-23-14-18(15-24-22)17-11-19(26-7-9-30-10-8-26)13-21(12-17)31(28,29)20-5-3-2-4-6-20/h2-6,11-15H,7-10H2,1H3,(H,23,24,25,27) UTJHTHZLECYYPO-UHFFFAOYSA-N 580818 N-(5-(3-morpholino-5- (phenylsulfonyl)phenyl)pyrimidin-2- yl)acetamide::US11492348, Compound 30 Serine/threonine-protein kinase mTOR Homo sapiens 10900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580818&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403547 475726654 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224455 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1)C(F)(F)F InChI=1S/C23H22F3N3O3S/c24-23(25,26)21-13-22(27)28-14-20(21)17-10-18(29-6-8-32-9-7-29)12-19(11-17)33(30,31)15-16-4-2-1-3-5-16/h1-5,10-14H,6-9,15H2,(H2,27,28) LVHZEQFUPUPOLU-UHFFFAOYSA-N 580820 5-(3-(benzylsulfonyl)-5-morpholinophenyl)- 4-(trifluoromethyl)pyridin-2-amine::US11492348, Compound 32 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 6300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580820&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177561 475726656 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224456 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1)C(F)(F)F InChI=1S/C23H22F3N3O3S/c24-23(25,26)21-13-22(27)28-14-20(21)17-10-18(29-6-8-32-9-7-29)12-19(11-17)33(30,31)15-16-4-2-1-3-5-16/h1-5,10-14H,6-9,15H2,(H2,27,28) LVHZEQFUPUPOLU-UHFFFAOYSA-N 580820 5-(3-(benzylsulfonyl)-5-morpholinophenyl)- 4-(trifluoromethyl)pyridin-2-amine::US11492348, Compound 32 Serine/threonine-protein kinase mTOR Homo sapiens >33000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580820&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177561 475726656 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224457 OCCNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1 InChI=1S/C23H26N4O4S/c28-9-6-24-23-25-15-20(16-26-23)19-12-21(27-7-10-31-11-8-27)14-22(13-19)32(29,30)17-18-4-2-1-3-5-18/h1-5,12-16,28H,6-11,17H2,(H,24,25,26) AUFXEJFFYMFFGA-UHFFFAOYSA-N 580823 2-((5-(3-(benzylsulfonyl)-5- morpholinophenyl)pyrimidin-2- yl)amino)ethan-1-ol::US11492348, Compound 35 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 23490 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580823&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403539 475726659 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224458 OCCNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1)N1CCOCC1 InChI=1S/C23H26N4O4S/c28-9-6-24-23-25-15-20(16-26-23)19-12-21(27-7-10-31-11-8-27)14-22(13-19)32(29,30)17-18-4-2-1-3-5-18/h1-5,12-16,28H,6-11,17H2,(H,24,25,26) AUFXEJFFYMFFGA-UHFFFAOYSA-N 580823 2-((5-(3-(benzylsulfonyl)-5- morpholinophenyl)pyrimidin-2- yl)amino)ethan-1-ol::US11492348, Compound 35 Serine/threonine-protein kinase mTOR Homo sapiens 12200 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580823&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403539 475726659 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224459 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CC1CCOC1)N1CCOCC1 InChI=1S/C19H24N4O4S/c20-19-21-10-16(11-22-19)15-7-17(23-2-5-26-6-3-23)9-18(8-15)28(24,25)13-14-1-4-27-12-14/h7-11,14H,1-6,12-13H2,(H2,20,21,22) PBDNSQIGSLIDQF-UHFFFAOYSA-N 580826 5-(3-morpholino-5-(((tetrahydrofuran-3- yl)methyl)sulfonyl)phenyl)pyrimidin-2- amine::US11492348, Compound 38 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 9110 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580826&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173124 475726662 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224460 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CC1CCOC1)N1CCOCC1 InChI=1S/C19H24N4O4S/c20-19-21-10-16(11-22-19)15-7-17(23-2-5-26-6-3-23)9-18(8-15)28(24,25)13-14-1-4-27-12-14/h7-11,14H,1-6,12-13H2,(H2,20,21,22) PBDNSQIGSLIDQF-UHFFFAOYSA-N 580826 5-(3-morpholino-5-(((tetrahydrofuran-3- yl)methyl)sulfonyl)phenyl)pyrimidin-2- amine::US11492348, Compound 38 Serine/threonine-protein kinase mTOR Homo sapiens 3600 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580826&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173124 475726662 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224461 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CC1CCOCC1)N1CCOCC1 InChI=1S/C20H26N4O4S/c21-20-22-12-17(13-23-20)16-9-18(24-3-7-28-8-4-24)11-19(10-16)29(25,26)14-15-1-5-27-6-2-15/h9-13,15H,1-8,14H2,(H2,21,22,23) FKLPBMTYUBSJAH-UHFFFAOYSA-N 580827 5-(3-morpholino-5-(((tetrahydro-2H-pyran- 4-yl)methyl)sulfonyl)phenyl)pyrimidin-2- amine::US11492348, Compound 39 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 9900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580827&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403575 475726663 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224462 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CC1CCOCC1)N1CCOCC1 InChI=1S/C20H26N4O4S/c21-20-22-12-17(13-23-20)16-9-18(24-3-7-28-8-4-24)11-19(10-16)29(25,26)14-15-1-5-27-6-2-15/h9-13,15H,1-8,14H2,(H2,21,22,23) FKLPBMTYUBSJAH-UHFFFAOYSA-N 580827 5-(3-morpholino-5-(((tetrahydro-2H-pyran- 4-yl)methyl)sulfonyl)phenyl)pyrimidin-2- amine::US11492348, Compound 39 Serine/threonine-protein kinase mTOR Homo sapiens 4800 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580827&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403575 475726663 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224463 Oc1cccc(c1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C23H22FNO4S/c24-20-6-4-17(5-7-20)16-30(27,28)23-14-19(18-2-1-3-22(26)13-18)12-21(15-23)25-8-10-29-11-9-25/h1-7,12-15,26H,8-11,16H2 GNPGNLUFMXYLDV-UHFFFAOYSA-N 580829 3'-((4-fluorobenzyl)sulfonyl)-5'-morpholino- [1,1'-biphenyl]-3-ol::US11492348, Compound 41 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 860 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580829&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177453 475726665 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224464 Oc1cccc(c1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C23H22FNO4S/c24-20-6-4-17(5-7-20)16-30(27,28)23-14-19(18-2-1-3-22(26)13-18)12-21(15-23)25-8-10-29-11-9-25/h1-7,12-15,26H,8-11,16H2 GNPGNLUFMXYLDV-UHFFFAOYSA-N 580829 3'-((4-fluorobenzyl)sulfonyl)-5'-morpholino- [1,1'-biphenyl]-3-ol::US11492348, Compound 41 Serine/threonine-protein kinase mTOR Homo sapiens 4270 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580829&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177453 475726665 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224465 NCCNc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C23H26FN5O3S/c24-20-3-1-17(2-4-20)16-33(30,31)22-12-18(11-21(13-22)29-7-9-32-10-8-29)19-14-27-23(28-15-19)26-6-5-25/h1-4,11-15H,5-10,16,25H2,(H,26,27,28) SQJXKDBFQOBHDB-UHFFFAOYSA-N 580835 N1-(5-(3-((4-fluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-yl)ethane- 1,2-diamine::US11492348, Compound 47 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 2180 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580835&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177391 475726671 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224466 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1c[nH]c2ccccc12)N1CCOCC1 InChI=1S/C23H23N5O3S/c24-23-26-12-17(13-27-23)16-9-19(28-5-7-31-8-6-28)11-20(10-16)32(29,30)15-18-14-25-22-4-2-1-3-21(18)22/h1-4,9-14,25H,5-8,15H2,(H2,24,26,27) UEARLLHPZNDKJH-UHFFFAOYSA-N 580836 5-(3-(((1H-indol-3-yl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 48 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human >50000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580836&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403544 475726672 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224467 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1c[nH]c2ccccc12)N1CCOCC1 InChI=1S/C23H23N5O3S/c24-23-26-12-17(13-27-23)16-9-19(28-5-7-31-8-6-28)11-20(10-16)32(29,30)15-18-14-25-22-4-2-1-3-21(18)22/h1-4,9-14,25H,5-8,15H2,(H2,24,26,27) UEARLLHPZNDKJH-UHFFFAOYSA-N 580836 5-(3-(((1H-indol-3-yl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 48 Serine/threonine-protein kinase mTOR Homo sapiens 6390 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580836&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403544 475726672 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224468 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCCCC1)N1CCOCC1 InChI=1S/C20H26N4O3S/c21-20-22-13-16(14-23-20)15-10-17(24-6-8-27-9-7-24)12-19(11-15)28(25,26)18-4-2-1-3-5-18/h10-14,18H,1-9H2,(H2,21,22,23) KDLQRPLIGSYUGT-UHFFFAOYSA-N 580837 5-(3-(cyclohexylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 49 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 31100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580837&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177399 475726673 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224469 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1F)N1CCOCC1 InChI=1S/C21H21FN4O3S/c22-20-4-2-1-3-15(20)14-30(27,28)19-10-16(17-12-24-21(23)25-13-17)9-18(11-19)26-5-7-29-8-6-26/h1-4,9-13H,5-8,14H2,(H2,23,24,25) QAAKCQGAMWFSQA-UHFFFAOYSA-N 580838 5-(3-((2-fluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 50 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human >50000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580838&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403585 475726674 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224470 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccccc1F)N1CCOCC1 InChI=1S/C21H21FN4O3S/c22-20-4-2-1-3-15(20)14-30(27,28)19-10-16(17-12-24-21(23)25-13-17)9-18(11-19)26-5-7-29-8-6-26/h1-4,9-13H,5-8,14H2,(H2,23,24,25) QAAKCQGAMWFSQA-UHFFFAOYSA-N 580838 5-(3-((2-fluorobenzyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 50 Serine/threonine-protein kinase mTOR Homo sapiens 2980 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580838&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403585 475726674 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224471 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-20-10-14(11-21-18)13-7-15(22-2-5-25-6-3-22)9-17(8-13)27(23,24)16-1-4-26-12-16/h7-11,16H,1-6,12H2,(H2,19,20,21) JOSFJDYSRMQQQE-UHFFFAOYSA-N 580839 5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 51 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 2120 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580839&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173036 475726675 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224472 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-20-10-14(11-21-18)13-7-15(22-2-5-25-6-3-22)9-17(8-13)27(23,24)16-1-4-26-12-16/h7-11,16H,1-6,12H2,(H2,19,20,21) JOSFJDYSRMQQQE-UHFFFAOYSA-N 580839 5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 51 Serine/threonine-protein kinase mTOR Homo sapiens 460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580839&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173036 475726675 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224473 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-20-10-14(11-21-18)13-7-15(22-2-5-25-6-3-22)9-17(8-13)27(23,24)16-1-4-26-12-16/h7-11,16H,1-6,12H2,(H2,19,20,21)/t16-/m1/s1 JOSFJDYSRMQQQE-MRXNPFEDSA-N 580840 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 52 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 3460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580840&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173035 475726676 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224474 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-20-10-14(11-21-18)13-7-15(22-2-5-25-6-3-22)9-17(8-13)27(23,24)16-1-4-26-12-16/h7-11,16H,1-6,12H2,(H2,19,20,21)/t16-/m1/s1 JOSFJDYSRMQQQE-MRXNPFEDSA-N 580840 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 52 Serine/threonine-protein kinase mTOR Homo sapiens 730 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580840&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173035 475726676 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224475 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@H]1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-20-10-14(11-21-18)13-7-15(22-2-5-25-6-3-22)9-17(8-13)27(23,24)16-1-4-26-12-16/h7-11,16H,1-6,12H2,(H2,19,20,21)/t16-/m0/s1 JOSFJDYSRMQQQE-INIZCTEOSA-N 580841 (S)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 53 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 1650 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580841&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177521 475726677 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224476 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@H]1CCOC1)N1CCOCC1 InChI=1S/C18H22N4O4S/c19-18-20-10-14(11-21-18)13-7-15(22-2-5-25-6-3-22)9-17(8-13)27(23,24)16-1-4-26-12-16/h7-11,16H,1-6,12H2,(H2,19,20,21)/t16-/m0/s1 JOSFJDYSRMQQQE-INIZCTEOSA-N 580841 (S)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 53 Serine/threonine-protein kinase mTOR Homo sapiens 540 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580841&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177521 475726677 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224477 CC(C)(C)OC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H29N5O5S/c1-22(2,3)32-21(28)27-13-19(14-27)33(29,30)18-9-15(16-11-24-20(23)25-12-16)8-17(10-18)26-4-6-31-7-5-26/h8-12,19H,4-7,13-14H2,1-3H3,(H2,23,24,25) BYFFRDOLDMUBDX-UHFFFAOYSA-N 580842 US11492348, Compound 54::tert-butyl 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidine-1- carboxylate RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 2460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580842&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173019 475726678 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224478 CC(C)(C)OC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H29N5O5S/c1-22(2,3)32-21(28)27-13-19(14-27)33(29,30)18-9-15(16-11-24-20(23)25-12-16)8-17(10-18)26-4-6-31-7-5-26/h8-12,19H,4-7,13-14H2,1-3H3,(H2,23,24,25) BYFFRDOLDMUBDX-UHFFFAOYSA-N 580842 US11492348, Compound 54::tert-butyl 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidine-1- carboxylate Serine/threonine-protein kinase mTOR Homo sapiens 590 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580842&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173019 475726678 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224479 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc2[nH]ccc2c1)N1CCOCC1 InChI=1S/C23H23N5O3S/c24-23-26-13-19(14-27-23)18-10-20(28-5-7-31-8-6-28)12-21(11-18)32(29,30)15-16-1-2-22-17(9-16)3-4-25-22/h1-4,9-14,25H,5-8,15H2,(H2,24,26,27) XJDISKLIAOIKHD-UHFFFAOYSA-N 580844 5-(3-(((1H-indol-5-yl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 56 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 19760 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580844&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177523 475726680 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224480 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc2[nH]ccc2c1)N1CCOCC1 InChI=1S/C23H23N5O3S/c24-23-26-13-19(14-27-23)18-10-20(28-5-7-31-8-6-28)12-21(11-18)32(29,30)15-16-1-2-22-17(9-16)3-4-25-22/h1-4,9-14,25H,5-8,15H2,(H2,24,26,27) XJDISKLIAOIKHD-UHFFFAOYSA-N 580844 5-(3-(((1H-indol-5-yl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 56 Serine/threonine-protein kinase mTOR Homo sapiens 6150 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580844&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177523 475726680 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224481 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(NS(N)(=O)=O)cc1)N1CCOCC1 InChI=1S/C21H24N6O5S2/c22-21-24-12-17(13-25-21)16-9-19(27-5-7-32-8-6-27)11-20(10-16)33(28,29)14-15-1-3-18(4-2-15)26-34(23,30)31/h1-4,9-13,26H,5-8,14H2,(H2,22,24,25)(H2,23,30,31) AIEZAQLQTGRIBK-UHFFFAOYSA-N 580845 N-(4-(((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)methyl)phenyl) methanesulfonamide::US11492348, Compound 57 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 19750 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580845&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 166594436 475726681 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224482 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(NS(N)(=O)=O)cc1)N1CCOCC1 InChI=1S/C21H24N6O5S2/c22-21-24-12-17(13-25-21)16-9-19(27-5-7-32-8-6-27)11-20(10-16)33(28,29)14-15-1-3-18(4-2-15)26-34(23,30)31/h1-4,9-13,26H,5-8,14H2,(H2,22,24,25)(H2,23,30,31) AIEZAQLQTGRIBK-UHFFFAOYSA-N 580845 N-(4-(((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)methyl)phenyl) methanesulfonamide::US11492348, Compound 57 Serine/threonine-protein kinase mTOR Homo sapiens 3440 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580845&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 166594436 475726681 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224483 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(cc1)N1CCOCC1)N1CCOCC1 InChI=1S/C25H29N5O4S/c26-25-27-16-21(17-28-25)20-13-23(30-7-11-34-12-8-30)15-24(14-20)35(31,32)18-19-1-3-22(4-2-19)29-5-9-33-10-6-29/h1-4,13-17H,5-12,18H2,(H2,26,27,28) LVUSAPAAXSOAIN-UHFFFAOYSA-N 580846 5-(3-morpholino-5-((4- morpholinobenzyl)sulfonyl)phenyl) pyrimidin-2-amine::US11492348, Compound 58 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 41290 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580846&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177568 475726682 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224484 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(cc1)N1CCOCC1)N1CCOCC1 InChI=1S/C25H29N5O4S/c26-25-27-16-21(17-28-25)20-13-23(30-7-11-34-12-8-30)15-24(14-20)35(31,32)18-19-1-3-22(4-2-19)29-5-9-33-10-6-29/h1-4,13-17H,5-12,18H2,(H2,26,27,28) LVUSAPAAXSOAIN-UHFFFAOYSA-N 580846 5-(3-morpholino-5-((4- morpholinobenzyl)sulfonyl)phenyl) pyrimidin-2-amine::US11492348, Compound 58 Serine/threonine-protein kinase mTOR Homo sapiens 3950 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580846&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177568 475726682 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224485 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1c[nH]cn1)N1CCOCC1 InChI=1S/C18H20N6O3S/c19-18-21-8-14(9-22-18)13-5-16(24-1-3-27-4-2-24)7-17(6-13)28(25,26)11-15-10-20-12-23-15/h5-10,12H,1-4,11H2,(H,20,23)(H2,19,21,22) FXBITLRVSYFNLQ-UHFFFAOYSA-N 580847 5-(3-(((1H-imidazol-4-yl)methyl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 59 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 36090 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580847&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403589 475726683 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224486 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1c[nH]cn1)N1CCOCC1 InChI=1S/C18H20N6O3S/c19-18-21-8-14(9-22-18)13-5-16(24-1-3-27-4-2-24)7-17(6-13)28(25,26)11-15-10-20-12-23-15/h5-10,12H,1-4,11H2,(H,20,23)(H2,19,21,22) FXBITLRVSYFNLQ-UHFFFAOYSA-N 580847 5-(3-(((1H-imidazol-4-yl)methyl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 59 Serine/threonine-protein kinase mTOR Homo sapiens 4600 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580847&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403589 475726683 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224487 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CC1CCCCC1)N1CCOCC1 InChI=1S/C21H28N4O3S/c22-21-23-13-18(14-24-21)17-10-19(25-6-8-28-9-7-25)12-20(11-17)29(26,27)15-16-4-2-1-3-5-16/h10-14,16H,1-9,15H2,(H2,22,23,24) UGNHRUPSHOBCAE-UHFFFAOYSA-N 580848 5-(3-((cyclohexylmethyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 60 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 31120 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580848&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403572 475726684 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224488 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOCC1)N1CCOCC1 InChI=1S/C19H24N4O4S/c20-19-21-12-15(13-22-19)14-9-16(23-3-7-27-8-4-23)11-18(10-14)28(24,25)17-1-5-26-6-2-17/h9-13,17H,1-8H2,(H2,20,21,22) MNXDJZUAFAEDPV-UHFFFAOYSA-N 580850 5-(3-morpholino-5-((tetrahydro-2H-pyran-4- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 62 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 6470 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580850&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403554 475726686 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224489 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOCC1)N1CCOCC1 InChI=1S/C19H24N4O4S/c20-19-21-12-15(13-22-19)14-9-16(23-3-7-27-8-4-23)11-18(10-14)28(24,25)17-1-5-26-6-2-17/h9-13,17H,1-8H2,(H2,20,21,22) MNXDJZUAFAEDPV-UHFFFAOYSA-N 580850 5-(3-morpholino-5-((tetrahydro-2H-pyran-4- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 62 Serine/threonine-protein kinase mTOR Homo sapiens 1870 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580850&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403554 475726686 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224490 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc2[nH]cnc2c1)N1CCOCC1 InChI=1S/C22H22N6O3S/c23-22-24-11-17(12-25-22)16-8-18(28-3-5-31-6-4-28)10-19(9-16)32(29,30)13-15-1-2-20-21(7-15)27-14-26-20/h1-2,7-12,14H,3-6,13H2,(H,26,27)(H2,23,24,25) QSULAKNUOMLTTH-UHFFFAOYSA-N 580851 5-(3-(((1H-benzo[d]imidazol-5- yl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 63 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 3710 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580851&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177565 475726687 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224491 CC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C19H23N5O4S/c1-13(25)24-11-18(12-24)29(26,27)17-7-14(15-9-21-19(20)22-10-15)6-16(8-17)23-2-4-28-5-3-23/h6-10,18H,2-5,11-12H2,1H3,(H2,20,21,22) REVVXZMXEHLSOS-UHFFFAOYSA-N 580856 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1- yl)ethan-1-one::US11492348, Compound 68 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 4660 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580856&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177412 475726692 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224492 CC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C19H23N5O4S/c1-13(25)24-11-18(12-24)29(26,27)17-7-14(15-9-21-19(20)22-10-15)6-16(8-17)23-2-4-28-5-3-23/h6-10,18H,2-5,11-12H2,1H3,(H2,20,21,22) REVVXZMXEHLSOS-UHFFFAOYSA-N 580856 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1- yl)ethan-1-one::US11492348, Compound 68 Serine/threonine-protein kinase mTOR Homo sapiens 1210 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580856&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177412 475726692 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224493 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOC1)N1CCOCC1)C(F)(F)F InChI=1S/C20H22F3N3O4S/c21-20(22,23)18-10-19(24)25-11-17(18)13-7-14(26-2-5-29-6-3-26)9-16(8-13)31(27,28)15-1-4-30-12-15/h7-11,15H,1-6,12H2,(H2,24,25) ABFSEKIPQPPYFD-UHFFFAOYSA-N 580858 5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-4- (trifluoromethyl)pyridin-2-amine::US11492348, Compound 70 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 4020 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580858&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177452 475726694 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224494 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCOC1)N1CCOCC1)C(F)(F)F InChI=1S/C20H22F3N3O4S/c21-20(22,23)18-10-19(24)25-11-17(18)13-7-14(26-2-5-29-6-3-26)9-16(8-13)31(27,28)15-1-4-30-12-15/h7-11,15H,1-6,12H2,(H2,24,25) ABFSEKIPQPPYFD-UHFFFAOYSA-N 580858 5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-4- (trifluoromethyl)pyridin-2-amine::US11492348, Compound 70 Serine/threonine-protein kinase mTOR Homo sapiens 7610 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580858&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177452 475726694 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224495 Nc1cc(c(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1)C(F)(F)F InChI=1S/C20H22F3N3O4S/c21-20(22,23)18-10-19(24)25-11-17(18)13-7-14(26-2-5-29-6-3-26)9-16(8-13)31(27,28)15-1-4-30-12-15/h7-11,15H,1-6,12H2,(H2,24,25)/t15-/m1/s1 ABFSEKIPQPPYFD-OAHLLOKOSA-N 580859 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-4- (trifluoromethyl)pyridin-2-amine::US11492348, Compound 71 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 11200 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580859&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177455 475726695 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224496 Nc1ncc(-c2cc(cc(c2)S(=O)(=O)C2CCOC2)N2CCOCC2)c(n1)C(F)(F)F InChI=1S/C19H21F3N4O4S/c20-19(21,22)17-16(10-24-18(23)25-17)12-7-13(26-2-5-29-6-3-26)9-15(8-12)31(27,28)14-1-4-30-11-14/h7-10,14H,1-6,11H2,(H2,23,24,25) CMGJJOGJVKPERQ-UHFFFAOYSA-N 580860 5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-4- (trifluoromethyl)pyrimidin-2-amine::US11492348, Compound 72 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 9130 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580860&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177509 475726696 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224497 CCC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H25N5O4S/c1-2-19(26)25-12-18(13-25)30(27,28)17-8-14(15-10-22-20(21)23-11-15)7-16(9-17)24-3-5-29-6-4-24/h7-11,18H,2-6,12-13H2,1H3,(H2,21,22,23) MYSAQBRFMVZHGR-UHFFFAOYSA-N 580863 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1- yl)propan-1-one::US11492348, Compound 75 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 6400 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580863&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403595 475726699 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224498 CC(C)C(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H27N5O4S/c1-14(2)20(27)26-12-19(13-26)31(28,29)18-8-15(16-10-23-21(22)24-11-16)7-17(9-18)25-3-5-30-6-4-25/h7-11,14,19H,3-6,12-13H2,1-2H3,(H2,22,23,24) SMNRAFUKBPHRSF-UHFFFAOYSA-N 580864 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1-yl)-2- methylpropan-1-one::US11492348, Compound 76 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 5640 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580864&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403580 475726700 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224499 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CN(C1)C(=O)C1CC1)N1CCOCC1 InChI=1S/C21H25N5O4S/c22-21-23-10-16(11-24-21)15-7-17(25-3-5-30-6-4-25)9-18(8-15)31(28,29)19-12-26(13-19)20(27)14-1-2-14/h7-11,14,19H,1-6,12-13H2,(H2,22,23,24) GQPLKKMMMCWSGR-UHFFFAOYSA-N 580865 (3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1- yl)(cyclopropyl)methanone::US11492348, Compound 77 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 3190 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580865&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173230 475726701 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224500 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CN(C1)C(=O)Cc1ccc(F)cc1)N1CCOCC1 InChI=1S/C25H26FN5O4S/c26-20-3-1-17(2-4-20)9-24(32)31-15-23(16-31)36(33,34)22-11-18(19-13-28-25(27)29-14-19)10-21(12-22)30-5-7-35-8-6-30/h1-4,10-14,23H,5-9,15-16H2,(H2,27,28,29) BKEZTGYVYYPAKU-UHFFFAOYSA-N 580866 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1-yl)-2- (4-fluorophenyl)ethan-1-one::US11492348, Compound 78 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 4520 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580866&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403587 475726702 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224501 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CN(C1)C(=O)c1ccc(F)cc1)N1CCOCC1 InChI=1S/C24H24FN5O4S/c25-19-3-1-16(2-4-19)23(31)30-14-22(15-30)35(32,33)21-10-17(18-12-27-24(26)28-13-18)9-20(11-21)29-5-7-34-8-6-29/h1-4,9-13,22H,5-8,14-15H2,(H2,26,27,28) FUMKWTBAGZSSPX-UHFFFAOYSA-N 580867 (3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1-yl)(4- fluorophenyl)methanone::US11492348, Compound 79 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 5020 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580867&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403588 475726703 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224502 NC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C18H22N6O4S/c19-17-21-8-13(9-22-17)12-5-14(23-1-3-28-4-2-23)7-15(6-12)29(26,27)16-10-24(11-16)18(20)25/h5-9,16H,1-4,10-11H2,(H2,20,25)(H2,19,21,22) DQCCJKOIQDDDJX-UHFFFAOYSA-N 580869 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidine-1- carboxamide::US11492348, Compound 81 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 26400 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580869&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177464 475726705 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224503 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)CCc1ccc(F)cc1)N1CCOCC1 InChI=1S/C22H23FN4O3S/c23-19-3-1-16(2-4-19)5-10-31(28,29)21-12-17(18-14-25-22(24)26-15-18)11-20(13-21)27-6-8-30-9-7-27/h1-4,11-15H,5-10H2,(H2,24,25,26) KBLZPRZOOCVKTQ-UHFFFAOYSA-N 580870 5-(3-((4-fluorophenethyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 82 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 10780 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580870&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177461 475726706 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224504 CC(=O)N1CCC(CC1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H27N5O4S/c1-15(27)25-4-2-19(3-5-25)31(28,29)20-11-16(17-13-23-21(22)24-14-17)10-18(12-20)26-6-8-30-9-7-26/h10-14,19H,2-9H2,1H3,(H2,22,23,24) LAKDHMSJDPGPMD-UHFFFAOYSA-N 580871 1-(4-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)piperidin-1- yl)ethan-1-one::US11492348, Compound 83 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 8470 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580871&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177458 475726707 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224505 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C(F)(F)c1ccccc1)N1CCOCC1 InChI=1S/C21H20F2N4O3S/c22-21(23,17-4-2-1-3-5-17)31(28,29)19-11-15(16-13-25-20(24)26-14-16)10-18(12-19)27-6-8-30-9-7-27/h1-5,10-14H,6-9H2,(H2,24,25,26) LAYSHJBZMVAZOG-UHFFFAOYSA-N 580875 5-(3-((difluoro(phenyl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 87 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 1000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580875&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173028 475726711 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224506 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C(F)(F)c1ccccc1)N1CCOCC1 InChI=1S/C21H20F2N4O3S/c22-21(23,17-4-2-1-3-5-17)31(28,29)19-11-15(16-13-25-20(24)26-14-16)10-18(12-19)27-6-8-30-9-7-27/h1-5,10-14H,6-9H2,(H2,24,25,26) LAYSHJBZMVAZOG-UHFFFAOYSA-N 580875 5-(3-((difluoro(phenyl)methyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 87 Serine/threonine-protein kinase mTOR Homo sapiens 1440 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580875&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173028 475726711 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224507 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCC(F)(F)CC1)N1CCOCC1 InChI=1S/C20H24F2N4O3S/c21-20(22)3-1-17(2-4-20)30(27,28)18-10-14(15-12-24-19(23)25-13-15)9-16(11-18)26-5-7-29-8-6-26/h9-13,17H,1-8H2,(H2,23,24,25) JIVNHRQMFVKICN-UHFFFAOYSA-N 580876 5-(3-((4,4-difluorocyclohexyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 88 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 6540 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580876&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177459 475726712 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224508 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1CCC(F)(F)CC1)N1CCOCC1 InChI=1S/C20H24F2N4O3S/c21-20(22)3-1-17(2-4-20)30(27,28)18-10-14(15-12-24-19(23)25-13-15)9-16(11-18)26-5-7-29-8-6-26/h9-13,17H,1-8H2,(H2,23,24,25) JIVNHRQMFVKICN-UHFFFAOYSA-N 580876 5-(3-((4,4-difluorocyclohexyl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 88 Serine/threonine-protein kinase mTOR Homo sapiens 2460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580876&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177459 475726712 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224509 CC(=O)N1CCC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H25N5O4S/c1-14(26)25-3-2-18(13-25)30(27,28)19-9-15(16-11-22-20(21)23-12-16)8-17(10-19)24-4-6-29-7-5-24/h8-12,18H,2-7,13H2,1H3,(H2,21,22,23) YMNYQOBKIRPWSR-UHFFFAOYSA-N 580879 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)pyrrolidin-1- yl)ethan-1-one::US11492348, Compound 91 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 7330 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580879&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177460 475726715 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224510 CC(=O)N1CCC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H25N5O4S/c1-14(26)25-3-2-18(13-25)30(27,28)19-9-15(16-11-22-20(21)23-12-16)8-17(10-19)24-4-6-29-7-5-24/h8-12,18H,2-7,13H2,1H3,(H2,21,22,23) YMNYQOBKIRPWSR-UHFFFAOYSA-N 580879 1-(3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)pyrrolidin-1- yl)ethan-1-one::US11492348, Compound 91 Serine/threonine-protein kinase mTOR Homo sapiens 2580 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580879&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177460 475726715 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224511 CC(C)(C)NC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C22H30N6O4S/c1-22(2,3)26-21(29)28-13-19(14-28)33(30,31)18-9-15(16-11-24-20(23)25-12-16)8-17(10-18)27-4-6-32-7-5-27/h8-12,19H,4-7,13-14H2,1-3H3,(H,26,29)(H2,23,24,25) LKWHZSGIFUMCLX-UHFFFAOYSA-N 580880 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N-(tert- butyl)azetidine-1-carboxamide::US11492348, Compound 92 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 2910 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580880&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403551 475726716 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224512 CCNC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H26N6O4S/c1-2-22-20(27)26-12-18(13-26)31(28,29)17-8-14(15-10-23-19(21)24-11-15)7-16(9-17)25-3-5-30-6-4-25/h7-11,18H,2-6,12-13H2,1H3,(H,22,27)(H2,21,23,24) RBTWNXQTOCPFLO-UHFFFAOYSA-N 580881 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N- ethylazetidine-1-carboxamide::US11492348, Compound 93 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 5440 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580881&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146175459 475726717 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224513 CCNC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H26N6O4S/c1-2-22-20(27)26-12-18(13-26)31(28,29)17-8-14(15-10-23-19(21)24-11-15)7-16(9-17)25-3-5-30-6-4-25/h7-11,18H,2-6,12-13H2,1H3,(H,22,27)(H2,21,23,24) RBTWNXQTOCPFLO-UHFFFAOYSA-N 580881 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N- ethylazetidine-1-carboxamide::US11492348, Compound 93 Serine/threonine-protein kinase mTOR Homo sapiens 870 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580881&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146175459 475726717 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224514 COCNC(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H26N6O5S/c1-30-13-24-20(27)26-11-18(12-26)32(28,29)17-7-14(15-9-22-19(21)23-10-15)6-16(8-17)25-2-4-31-5-3-25/h6-10,18H,2-5,11-13H2,1H3,(H,24,27)(H2,21,22,23) ADHPKXSCGCUVNC-UHFFFAOYSA-N 580882 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N- (methoxymethyl)azetidine-1-carboxamide::US11492348, Compound 94 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 19840 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580882&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403584 475726718 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224515 CN(C)C(=O)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H26N6O4S/c1-24(2)20(27)26-12-18(13-26)31(28,29)17-8-14(15-10-22-19(21)23-11-15)7-16(9-17)25-3-5-30-6-4-25/h7-11,18H,3-6,12-13H2,1-2H3,(H2,21,22,23) HHRCZUVDMACSEU-UHFFFAOYSA-N 580883 3-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)-N,N- dimethylazetidine-1-carboxamide::US11492348, Compound 95 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 5190 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580883&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403576 475726719 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224516 Nc1ccc(nn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccc(F)cc1F)N1CCOCC1 InChI=1S/C21H20F2N4O3S/c22-16-2-1-14(19(23)11-16)13-31(28,29)18-10-15(20-3-4-21(24)26-25-20)9-17(12-18)27-5-7-30-8-6-27/h1-4,9-12H,5-8,13H2,(H2,24,26) PTCBOMFJHXSNJC-UHFFFAOYSA-N 580884 6-(3-((2,4-difluorobenzyl)sulfonyl)-5- morpholinophenyl)pyridazin-3-amine::US11492348, Compound 96 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 1060 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580884&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177526 475726720 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224517 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)Cc1ccncc1)N1CCOCC1 InChI=1S/C20H21N5O3S/c21-20-23-12-17(13-24-20)16-9-18(25-5-7-28-8-6-25)11-19(10-16)29(26,27)14-15-1-3-22-4-2-15/h1-4,9-13H,5-8,14H2,(H2,21,23,24) CODANOSHVFIHQI-UHFFFAOYSA-N 580885 5-(3-morpholino-5-((pyridin-4- ylmethyl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 97 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 12370 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580885&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177525 475726721 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224518 Nc1ncc(cc1C(F)(F)F)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C20H22F3N3O4S/c21-20(22,23)18-9-14(11-25-19(18)24)13-7-15(26-2-5-29-6-3-26)10-17(8-13)31(27,28)16-1-4-30-12-16/h7-11,16H,1-6,12H2,(H2,24,25)/t16-/m1/s1 MTRSYZORTNDHQH-MRXNPFEDSA-N 580888 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)-3- (trifluoromethyl)pyridin-2-amine::US11492348, Compound 100 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 48200 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580888&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177401 475726724 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224519 Nc1ccc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C19H23N3O4S/c20-19-2-1-14(12-21-19)15-9-16(22-4-7-25-8-5-22)11-18(10-15)27(23,24)17-3-6-26-13-17/h1-2,9-12,17H,3-8,13H2,(H2,20,21)/t17-/m1/s1 HUTDGWMBXAJTFX-QGZVFWFLSA-N 580889 (R)-5-(3-morpholino-5-((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 101 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 8530 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580889&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177400 475726725 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224520 O=C(C1CC1)N1CC(C1)S(=O)(=O)c1cc(cc(c1)-c1cnc(NC2CC2)nc1)N1CCOCC1 InChI=1S/C24H29N5O4S/c30-23(16-1-2-16)29-14-22(15-29)34(31,32)21-10-17(9-20(11-21)28-5-7-33-8-6-28)18-12-25-24(26-13-18)27-19-3-4-19/h9-13,16,19,22H,1-8,14-15H2,(H,25,26,27) PVGCVDXYYMLKTI-UHFFFAOYSA-N 580890 US11492348, Compound 102::cyclopropyl(3-((3-(2- (cyclopropylamino)pyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)azetidin-1- yl)methanone RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 6790 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580890&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177402 475726726 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224521 O=S(=O)(C1CCOC1)c1cc(cc(c1)-c1cnc(NC2CC2)nc1)N1CCOCC1 InChI=1S/C21H26N4O4S/c26-30(27,19-3-6-29-14-19)20-10-15(9-18(11-20)25-4-7-28-8-5-25)16-12-22-21(23-13-16)24-17-1-2-17/h9-13,17,19H,1-8,14H2,(H,22,23,24) RUNUGPBGQHZGLN-UHFFFAOYSA-N 580891 N-cyclopropyl-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyrimidin-2-amine::US11492348, Compound 103 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 5810 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580891&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177394 475726727 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224522 Nc1cc(F)c(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C19H22FN3O4S/c20-18-10-19(21)22-11-17(18)13-7-14(23-2-5-26-6-3-23)9-16(8-13)28(24,25)15-1-4-27-12-15/h7-11,15H,1-6,12H2,(H2,21,22)/t15-/m1/s1 WTSDUVPALLLEIC-OAHLLOKOSA-N 580894 (R)-4-fluoro-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 106 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 4100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580894&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177393 475726730 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224523 Nc1cc(F)c(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C19H22FN3O4S/c20-18-10-19(21)22-11-17(18)13-7-14(23-2-5-26-6-3-23)9-16(8-13)28(24,25)15-1-4-27-12-15/h7-11,15H,1-6,12H2,(H2,21,22)/t15-/m1/s1 WTSDUVPALLLEIC-OAHLLOKOSA-N 580894 (R)-4-fluoro-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 106 Serine/threonine-protein kinase mTOR Homo sapiens 1460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580894&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177393 475726730 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224524 Nc1cc(Cl)c(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C19H22ClN3O4S/c20-18-10-19(21)22-11-17(18)13-7-14(23-2-5-26-6-3-23)9-16(8-13)28(24,25)15-1-4-27-12-15/h7-11,15H,1-6,12H2,(H2,21,22)/t15-/m1/s1 DREGPUYHKUGXIX-OAHLLOKOSA-N 580895 (R)-4-chloro-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 107 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 3700 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580895&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177404 475726731 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224525 Nc1cc(Cl)c(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C19H22ClN3O4S/c20-18-10-19(21)22-11-17(18)13-7-14(23-2-5-26-6-3-23)9-16(8-13)28(24,25)15-1-4-27-12-15/h7-11,15H,1-6,12H2,(H2,21,22)/t15-/m1/s1 DREGPUYHKUGXIX-OAHLLOKOSA-N 580895 (R)-4-chloro-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 107 Serine/threonine-protein kinase mTOR Homo sapiens 4330 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580895&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177404 475726731 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224526 CNc1ccc(cn1)-c1cc(cc(c1)S(=O)(=O)[C@@H]1CCOC1)N1CCOCC1 InChI=1S/C20H25N3O4S/c1-21-20-3-2-15(13-22-20)16-10-17(23-5-8-26-9-6-23)12-19(11-16)28(24,25)18-4-7-27-14-18/h2-3,10-13,18H,4-9,14H2,1H3,(H,21,22)/t18-/m1/s1 NEBGGJXVTCYVRW-GOSISDBHSA-N 580896 (R)-N-methyl-5-(3-morpholino-5- ((tetrahydrofuran-3- yl)sulfonyl)phenyl)pyridin-2-amine::US11492348, Compound 108 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 4720 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580896&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177405 475726732 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224527 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1coc2ccccc12)N1CCOCC1 InChI=1S/C22H20N4O4S/c23-22-24-12-16(13-25-22)15-9-17(26-5-7-29-8-6-26)11-18(10-15)31(27,28)21-14-30-20-4-2-1-3-19(20)21/h1-4,9-14H,5-8H2,(H2,23,24,25) VHKNCLVJHQMXJP-UHFFFAOYSA-N 580897 5-(3-(benzofuran-3-ylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 109 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 15000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580897&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173222 475726733 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224528 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc2ccoc12)N1CCOCC1 InChI=1S/C22H20N4O4S/c23-22-24-13-17(14-25-22)16-10-18(26-5-8-29-9-6-26)12-19(11-16)31(27,28)20-3-1-2-15-4-7-30-21(15)20/h1-4,7,10-14H,5-6,8-9H2,(H2,23,24,25) XHNOMXWHDQWEPR-UHFFFAOYSA-N 580898 5-(3-(benzofuran-7-ylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 110 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 8700 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580898&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403578 475726734 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224529 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc2ccoc12)N1CCOCC1 InChI=1S/C22H20N4O4S/c23-22-24-13-17(14-25-22)16-10-18(26-5-8-29-9-6-26)12-19(11-16)31(27,28)20-3-1-2-15-4-7-30-21(15)20/h1-4,7,10-14H,5-6,8-9H2,(H2,23,24,25) XHNOMXWHDQWEPR-UHFFFAOYSA-N 580898 5-(3-(benzofuran-7-ylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 110 Serine/threonine-protein kinase mTOR Homo sapiens 9900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580898&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403578 475726734 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224530 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc2CCOc12)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-13-17(14-25-22)16-10-18(26-5-8-29-9-6-26)12-19(11-16)31(27,28)20-3-1-2-15-4-7-30-21(15)20/h1-3,10-14H,4-9H2,(H2,23,24,25) CHMWZOJYOCHQQM-UHFFFAOYSA-N 580899 5-(3-((2,3-dihydrobenzofuran-7-yl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 111 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 14500 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580899&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403574 475726735 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224531 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1cccc2CCOc12)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-13-17(14-25-22)16-10-18(26-5-8-29-9-6-26)12-19(11-16)31(27,28)20-3-1-2-15-4-7-30-21(15)20/h1-3,10-14H,4-9H2,(H2,23,24,25) CHMWZOJYOCHQQM-UHFFFAOYSA-N 580899 5-(3-((2,3-dihydrobenzofuran-7-yl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 111 Serine/threonine-protein kinase mTOR Homo sapiens 5400 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580899&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403574 475726735 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224532 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc2ccoc2c1)N1CCOCC1 InChI=1S/C22H20N4O4S/c23-22-24-13-17(14-25-22)16-9-18(26-4-7-29-8-5-26)11-20(10-16)31(27,28)19-2-1-15-3-6-30-21(15)12-19/h1-3,6,9-14H,4-5,7-8H2,(H2,23,24,25) DXYJIZGMAVBSRD-UHFFFAOYSA-N 580900 5-(3-(benzofuran-6-ylsulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 112 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 22300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580900&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177406 475726736 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224533 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)\C=C\c1ccccc1O)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-14-18(15-25-22)17-11-19(26-6-8-30-9-7-26)13-20(12-17)31(28,29)10-5-16-3-1-2-4-21(16)27/h1-5,10-15,27H,6-9H2,(H2,23,24,25)/b10-5+ VWSZMUAJTFRSBT-BJMVGYQFSA-N 580901 (E)-2-(2-((3-(2-aminopyrimidin-5-yl)-5- morpholinophenyl)sulfonyl)vinyl)phenol::US11492348, Compound 113 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 14300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580901&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173605 475726737 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224534 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1c[nH]c2ccccc12)N1CCOCC1 InChI=1S/C22H21N5O3S/c23-22-25-12-16(13-26-22)15-9-17(27-5-7-30-8-6-27)11-18(10-15)31(28,29)21-14-24-20-4-2-1-3-19(20)21/h1-4,9-14,24H,5-8H2,(H2,23,25,26) PTXPJFUWHPHQMQ-UHFFFAOYSA-N 580902 5-(3-((1H-indol-3-yl)sulfonyl)-5- morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 114 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 15300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580902&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177497 475726738 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224535 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)c1ccccc1 InChI=1S/C19H19N5O3S/c20-19-21-12-14(13-22-19)17-10-16(28(25,26)15-4-2-1-3-5-15)11-18(23-17)24-6-8-27-9-7-24/h1-5,10-13H,6-9H2,(H2,20,21,22) JKWJJSBYSROHTC-UHFFFAOYSA-N 580903 5-(6-morpholino-4-(phenylsulfonyl)pyridin- 2-yl)pyrimidin-2-amine::US11492348, Compound 115 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 570 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580903&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173051 475726739 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224536 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)c1ccccc1 InChI=1S/C19H19N5O3S/c20-19-21-12-14(13-22-19)17-10-16(28(25,26)15-4-2-1-3-5-15)11-18(23-17)24-6-8-27-9-7-24/h1-5,10-13H,6-9H2,(H2,20,21,22) JKWJJSBYSROHTC-UHFFFAOYSA-N 580903 5-(6-morpholino-4-(phenylsulfonyl)pyridin- 2-yl)pyrimidin-2-amine::US11492348, Compound 115 Serine/threonine-protein kinase mTOR Homo sapiens 63.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580903&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173051 475726739 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224537 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)c1ccc2CCOc2c1)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-13-17(14-25-22)16-9-18(26-4-7-29-8-5-26)11-20(10-16)31(27,28)19-2-1-15-3-6-30-21(15)12-19/h1-2,9-14H,3-8H2,(H2,23,24,25) XRAYWWJSERJSCZ-UHFFFAOYSA-N 580904 5-(3-((2,3-dihydrobenzofuran-6-yl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 116 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 22900 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580904&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177498 475726740 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224538 Nc1ncc(cn1)-c1cc(cc(n1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C19H19N5O3S/c20-19-21-12-14(13-22-19)17-10-15(24-6-8-27-9-7-24)11-18(23-17)28(25,26)16-4-2-1-3-5-16/h1-5,10-13H,6-9H2,(H2,20,21,22) ICLOQJROEDOSQW-UHFFFAOYSA-N 580905 5-(4-morpholino-6-(phenylsulfonyl)pyridin- 2-yl)pyrimidin-2-amine::US11492348, Compound 117 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 17300 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580905&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173118 475726741 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224539 Nc1ncc(cn1)-c1cc(nc(c1)S(=O)(=O)c1ccccc1)N1CCOCC1 InChI=1S/C19H19N5O3S/c20-19-21-12-15(13-22-19)14-10-17(24-6-8-27-9-7-24)23-18(11-14)28(25,26)16-4-2-1-3-5-16/h1-5,10-13H,6-9H2,(H2,20,21,22) JWQMKOMDJBLFAT-UHFFFAOYSA-N 580906 5-(2-morpholino-6-(phenylsulfonyl)pyridin- 4-yl)pyrimidin-2-amine::US11492348, Compound 118 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 13800 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580906&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173006 475726742 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224540 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1COc2ccccc12)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-12-16(13-25-22)15-9-17(26-5-7-29-8-6-26)11-18(10-15)31(27,28)21-14-30-20-4-2-1-3-19(20)21/h1-4,9-13,21H,5-8,14H2,(H2,23,24,25) GOTAIGHGVOKIIG-UHFFFAOYSA-N 580907 5-(3-((2,3-dihydrobenzofuran-3-yl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 119 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 4000 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580907&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173219 475726743 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224541 Nc1ncc(cn1)-c1cc(cc(c1)S(=O)(=O)C1COc2ccccc12)N1CCOCC1 InChI=1S/C22H22N4O4S/c23-22-24-12-16(13-25-22)15-9-17(26-5-7-29-8-6-26)11-18(10-15)31(27,28)21-14-30-20-4-2-1-3-19(20)21/h1-4,9-13,21H,5-8,14H2,(H2,23,24,25) GOTAIGHGVOKIIG-UHFFFAOYSA-N 580907 5-(3-((2,3-dihydrobenzofuran-3-yl)sulfonyl)- 5-morpholinophenyl)pyrimidin-2-amine::US11492348, Compound 119 Serine/threonine-protein kinase mTOR Homo sapiens 4700 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580907&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173219 475726743 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224542 Nc1ncc(cn1)-c1cc(Oc2ccccc2)cc(n1)N1CCOCC1 InChI=1S/C19H19N5O2/c20-19-21-12-14(13-22-19)17-10-16(26-15-4-2-1-3-5-15)11-18(23-17)24-6-8-25-9-7-24/h1-5,10-13H,6-9H2,(H2,20,21,22) NORCBTIZLLLLCH-UHFFFAOYSA-N 580908 5-(6-morpholino-4-phenoxypyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 120 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 640 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580908&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173263 475726744 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224543 Nc1ncc(cn1)-c1cc(Oc2ccccc2)cc(n1)N1CCOCC1 InChI=1S/C19H19N5O2/c20-19-21-12-14(13-22-19)17-10-16(26-15-4-2-1-3-5-15)11-18(23-17)24-6-8-25-9-7-24/h1-5,10-13H,6-9H2,(H2,20,21,22) NORCBTIZLLLLCH-UHFFFAOYSA-N 580908 5-(6-morpholino-4-phenoxypyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 120 Serine/threonine-protein kinase mTOR Homo sapiens 480 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580908&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173263 475726744 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224544 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)c1ccccc1 InChI=1S/C20H19N5O2/c21-20-22-12-16(13-23-20)17-10-15(19(26)14-4-2-1-3-5-14)11-18(24-17)25-6-8-27-9-7-25/h1-5,10-13H,6-9H2,(H2,21,22,23) LZKXBBBGUGTFQS-UHFFFAOYSA-N 580910 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(phenyl)methanone::US11492348, Compound 122 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 480 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580910&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173102 475726746 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224545 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)c1ccccc1 InChI=1S/C20H19N5O2/c21-20-22-12-16(13-23-20)17-10-15(19(26)14-4-2-1-3-5-14)11-18(24-17)25-6-8-27-9-7-25/h1-5,10-13H,6-9H2,(H2,21,22,23) LZKXBBBGUGTFQS-UHFFFAOYSA-N 580910 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(phenyl)methanone::US11492348, Compound 122 Serine/threonine-protein kinase mTOR Homo sapiens 510 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580910&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173102 475726746 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224546 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(F)(F)c1ccccc1 InChI=1S/C20H19F2N5O/c21-20(22,15-4-2-1-3-5-15)16-10-17(14-12-24-19(23)25-13-14)26-18(11-16)27-6-8-28-9-7-27/h1-5,10-13H,6-9H2,(H2,23,24,25) VYJVZMADYMHXLJ-UHFFFAOYSA-N 580911 5-(4-(difluoro(phenyl)methyl)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 123 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580911&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173013 475726747 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224547 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(F)(F)c1ccccc1 InChI=1S/C20H19F2N5O/c21-20(22,15-4-2-1-3-5-15)16-10-17(14-12-24-19(23)25-13-14)26-18(11-16)27-6-8-28-9-7-27/h1-5,10-13H,6-9H2,(H2,23,24,25) VYJVZMADYMHXLJ-UHFFFAOYSA-N 580911 5-(4-(difluoro(phenyl)methyl)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 123 Serine/threonine-protein kinase mTOR Homo sapiens 560 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580911&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173013 475726747 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224548 Nc1ncc(cn1)-c1cc(Cc2ccccc2)cc(n1)N1CCOCC1 InChI=1S/C20H21N5O/c21-20-22-13-17(14-23-20)18-11-16(10-15-4-2-1-3-5-15)12-19(24-18)25-6-8-26-9-7-25/h1-5,11-14H,6-10H2,(H2,21,22,23) BIBKDEWJEDPFAP-UHFFFAOYSA-N 580912 5-(4-benzyl-6-morpholinopyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 124 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 890 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580912&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177467 475726748 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224549 CC(c1ccccc1)c1cc(nc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H23N5O/c1-15(16-5-3-2-4-6-16)17-11-19(18-13-23-21(22)24-14-18)25-20(12-17)26-7-9-27-10-8-26/h2-6,11-15H,7-10H2,1H3,(H2,22,23,24) BOWLTCSRJMCFBE-UHFFFAOYSA-N 580913 5-(6-morpholino-4-(1-phenylethyl)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 125 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 810 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580913&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173030 475726749 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224550 CC(c1ccccc1)c1cc(nc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C21H23N5O/c1-15(16-5-3-2-4-6-16)17-11-19(18-13-23-21(22)24-14-18)25-20(12-17)26-7-9-27-10-8-26/h2-6,11-15H,7-10H2,1H3,(H2,22,23,24) BOWLTCSRJMCFBE-UHFFFAOYSA-N 580913 5-(6-morpholino-4-(1-phenylethyl)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 125 Serine/threonine-protein kinase mTOR Homo sapiens 270 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580913&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173030 475726749 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224551 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=C)c1ccccc1 InChI=1S/C21H21N5O/c1-15(16-5-3-2-4-6-16)17-11-19(18-13-23-21(22)24-14-18)25-20(12-17)26-7-9-27-10-8-26/h2-6,11-14H,1,7-10H2,(H2,22,23,24) ISNDHCBLFHJBMJ-UHFFFAOYSA-N 580914 5-(6-morpholino-4-(1-phenylvinyl)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 126 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 490 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580914&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173177 475726750 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224552 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C1(CC1)c1ccccc1 InChI=1S/C22H23N5O/c23-21-24-14-16(15-25-21)19-12-18(13-20(26-19)27-8-10-28-11-9-27)22(6-7-22)17-4-2-1-3-5-17/h1-5,12-15H,6-11H2,(H2,23,24,25) YUAITLJOHKMDAE-UHFFFAOYSA-N 580915 5-(6-morpholino-4-(1- phenylcyclopropyl)pyridin-2-yl)pyrimidin-2- amine::US11492348, Compound 127 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 380 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580915&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173125 475726751 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224553 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C1(CC1)c1ccccc1 InChI=1S/C22H23N5O/c23-21-24-14-16(15-25-21)19-12-18(13-20(26-19)27-8-10-28-11-9-27)22(6-7-22)17-4-2-1-3-5-17/h1-5,12-15H,6-11H2,(H2,23,24,25) YUAITLJOHKMDAE-UHFFFAOYSA-N 580915 5-(6-morpholino-4-(1- phenylcyclopropyl)pyridin-2-yl)pyrimidin-2- amine::US11492348, Compound 127 Serine/threonine-protein kinase mTOR Homo sapiens 130 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580915&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173125 475726751 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224554 Nc1ncc(cn1)-c1cc(OC2CN(C2)C(=O)C2CC2)cc(n1)N1CCOCC1 InChI=1S/C20H24N6O3/c21-20-22-9-14(10-23-20)17-7-15(8-18(24-17)25-3-5-28-6-4-25)29-16-11-26(12-16)19(27)13-1-2-13/h7-10,13,16H,1-6,11-12H2,(H2,21,22,23) ZUOOZRKTIWVPFW-UHFFFAOYSA-N 580917 (3-((2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)oxy)azetidin-1- yl)(cyclopropyl)methanone::US11492348, Compound 129 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 3460 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580917&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146173017 475726753 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224555 Nc1ncc(cn1)-c1cc(OC2CN(C2)C(=O)C2CC2)cc(n1)N1CCOCC1 InChI=1S/C20H24N6O3/c21-20-22-9-14(10-23-20)17-7-15(8-18(24-17)25-3-5-28-6-4-25)29-16-11-26(12-16)19(27)13-1-2-13/h7-10,13,16H,1-6,11-12H2,(H2,21,22,23) ZUOOZRKTIWVPFW-UHFFFAOYSA-N 580917 (3-((2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)oxy)azetidin-1- yl)(cyclopropyl)methanone::US11492348, Compound 129 Serine/threonine-protein kinase mTOR Homo sapiens 2950 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580917&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146173017 475726753 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224556 Nc1ncc(cn1)-c1cc(OC2CCOC2)cc(n1)N1CCOCC1 InChI=1S/C17H21N5O3/c18-17-19-9-12(10-20-17)15-7-14(25-13-1-4-24-11-13)8-16(21-15)22-2-5-23-6-3-22/h7-10,13H,1-6,11H2,(H2,18,19,20) BXETYAXZBHMEMY-UHFFFAOYSA-N 580918 5-(6-morpholino-4-((tetrahydrofuran-3- yl)oxy)pyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 130 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 750 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580918&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177529 475726754 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224557 Nc1ncc(cn1)-c1cc(OC2CCOC2)cc(n1)N1CCOCC1 InChI=1S/C17H21N5O3/c18-17-19-9-12(10-20-17)15-7-14(25-13-1-4-24-11-13)8-16(21-15)22-2-5-23-6-3-22/h7-10,13H,1-6,11H2,(H2,18,19,20) BXETYAXZBHMEMY-UHFFFAOYSA-N 580918 5-(6-morpholino-4-((tetrahydrofuran-3- yl)oxy)pyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 130 Serine/threonine-protein kinase mTOR Homo sapiens 1750 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580918&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177529 475726754 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224558 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)C1CCOCC1 InChI=1S/C19H23N5O3/c20-19-21-11-15(12-22-19)16-9-14(18(25)13-1-5-26-6-2-13)10-17(23-16)24-3-7-27-8-4-24/h9-13H,1-8H2,(H2,20,21,22) URYLXGQUXXMCGL-UHFFFAOYSA-N 580919 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(tetrahydro-2H- pyran-4-yl)methanone::US11492348, Compound 131 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 560 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580919&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177533 475726755 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224559 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)C1CCOCC1 InChI=1S/C19H23N5O3/c20-19-21-11-15(12-22-19)16-9-14(18(25)13-1-5-26-6-2-13)10-17(23-16)24-3-7-27-8-4-24/h9-13H,1-8H2,(H2,20,21,22) URYLXGQUXXMCGL-UHFFFAOYSA-N 580919 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(tetrahydro-2H- pyran-4-yl)methanone::US11492348, Compound 131 Serine/threonine-protein kinase mTOR Homo sapiens 590 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580919&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177533 475726755 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224560 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(F)(F)C1CCOCC1 InChI=1S/C19H23F2N5O2/c20-19(21,14-1-5-27-6-2-14)15-9-16(13-11-23-18(22)24-12-13)25-17(10-15)26-3-7-28-8-4-26/h9-12,14H,1-8H2,(H2,22,23,24) XFPYMWIXBOVFON-UHFFFAOYSA-N 580921 5-(4-(difluoro(tetrahydro-2H-pyran-4- yl)methyl)-6-morpholinopyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 133 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 400 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580921&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177531 475726756 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224561 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(F)(F)C1CCOCC1 InChI=1S/C19H23F2N5O2/c20-19(21,14-1-5-27-6-2-14)15-9-16(13-11-23-18(22)24-12-13)25-17(10-15)26-3-7-28-8-4-26/h9-12,14H,1-8H2,(H2,22,23,24) XFPYMWIXBOVFON-UHFFFAOYSA-N 580921 5-(4-(difluoro(tetrahydro-2H-pyran-4- yl)methyl)-6-morpholinopyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 133 Serine/threonine-protein kinase mTOR Homo sapiens 440 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580921&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177531 475726756 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224562 Nc1ncc(cn1)-c1cc(Oc2ccccc2Cl)cc(n1)N1CCOCC1 InChI=1S/C19H18ClN5O2/c20-15-3-1-2-4-17(15)27-14-9-16(13-11-22-19(21)23-12-13)24-18(10-14)25-5-7-26-8-6-25/h1-4,9-12H,5-8H2,(H2,21,22,23) SEZCHLLNKIYQLL-UHFFFAOYSA-N 580922 5-(4-(2-chlorophenoxy)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 134 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 380 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580922&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177530 475726757 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224563 Nc1ncc(cn1)-c1cc(Oc2ccccc2Cl)cc(n1)N1CCOCC1 InChI=1S/C19H18ClN5O2/c20-15-3-1-2-4-17(15)27-14-9-16(13-11-22-19(21)23-12-13)24-18(10-14)25-5-7-26-8-6-25/h1-4,9-12H,5-8H2,(H2,21,22,23) SEZCHLLNKIYQLL-UHFFFAOYSA-N 580922 5-(4-(2-chlorophenoxy)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 134 Serine/threonine-protein kinase mTOR Homo sapiens 450 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580922&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177530 475726757 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224564 COc1ccccc1Oc1cc(nc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H21N5O3/c1-26-17-4-2-3-5-18(17)28-15-10-16(14-12-22-20(21)23-13-14)24-19(11-15)25-6-8-27-9-7-25/h2-5,10-13H,6-9H2,1H3,(H2,21,22,23) YHJAWWBUBRTVQJ-UHFFFAOYSA-N 580923 5-(4-(2-methoxyphenoxy)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 135 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 1620 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580923&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177569 475726758 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224565 COc1ccccc1Oc1cc(nc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H21N5O3/c1-26-17-4-2-3-5-18(17)28-15-10-16(14-12-22-20(21)23-13-14)24-19(11-15)25-6-8-27-9-7-25/h2-5,10-13H,6-9H2,1H3,(H2,21,22,23) YHJAWWBUBRTVQJ-UHFFFAOYSA-N 580923 5-(4-(2-methoxyphenoxy)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 135 Serine/threonine-protein kinase mTOR Homo sapiens 700 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580923&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177569 475726758 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224566 Nc1ncc(cn1)-c1cc(Oc2ccccc2OC(F)(F)F)cc(n1)N1CCOCC1 InChI=1S/C20H18F3N5O3/c21-20(22,23)31-17-4-2-1-3-16(17)30-14-9-15(13-11-25-19(24)26-12-13)27-18(10-14)28-5-7-29-8-6-28/h1-4,9-12H,5-8H2,(H2,24,25,26) KHIUCPUWDPSZOH-UHFFFAOYSA-N 580924 5-(6-morpholino-4-(2- (trifluoromethoxy)phenoxy)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 136 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 1510 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580924&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403562 475726759 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224567 Nc1ncc(cn1)-c1cc(Oc2ccccc2OC(F)(F)F)cc(n1)N1CCOCC1 InChI=1S/C20H18F3N5O3/c21-20(22,23)31-17-4-2-1-3-16(17)30-14-9-15(13-11-25-19(24)26-12-13)27-18(10-14)28-5-7-29-8-6-28/h1-4,9-12H,5-8H2,(H2,24,25,26) KHIUCPUWDPSZOH-UHFFFAOYSA-N 580924 5-(6-morpholino-4-(2- (trifluoromethoxy)phenoxy)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 136 Serine/threonine-protein kinase mTOR Homo sapiens 2060 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580924&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 156403562 475726759 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224568 Cc1ccccc1Oc1cc(nc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H21N5O2/c1-14-4-2-3-5-18(14)27-16-10-17(15-12-22-20(21)23-13-15)24-19(11-16)25-6-8-26-9-7-25/h2-5,10-13H,6-9H2,1H3,(H2,21,22,23) STGMRFRVEBSQDM-UHFFFAOYSA-N 580925 5-(6-morpholino-4-(o-tolyloxy)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 137 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 450 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580925&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177566 475726760 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224569 Cc1ccccc1Oc1cc(nc(c1)-c1cnc(N)nc1)N1CCOCC1 InChI=1S/C20H21N5O2/c1-14-4-2-3-5-18(14)27-16-10-17(15-12-22-20(21)23-13-15)24-19(11-16)25-6-8-26-9-7-25/h2-5,10-13H,6-9H2,1H3,(H2,21,22,23) STGMRFRVEBSQDM-UHFFFAOYSA-N 580925 5-(6-morpholino-4-(o-tolyloxy)pyridin-2- yl)pyrimidin-2-amine::US11492348, Compound 137 Serine/threonine-protein kinase mTOR Homo sapiens 370 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580925&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177566 475726760 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224570 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)c1ccccc1Cl InChI=1S/C20H18ClN5O2/c21-16-4-2-1-3-15(16)19(27)13-9-17(14-11-23-20(22)24-12-14)25-18(10-13)26-5-7-28-8-6-26/h1-4,9-12H,5-8H2,(H2,22,23,24) XZOPDDDJHRZAKW-UHFFFAOYSA-N 580926 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(2- chlorophenyl)methanone::US11492348, Compound 138 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 190 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580926&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177570 475726761 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224571 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)C(=O)c1ccccc1Cl InChI=1S/C20H18ClN5O2/c21-16-4-2-1-3-15(16)19(27)13-9-17(14-11-23-20(22)24-12-14)25-18(10-13)26-5-7-28-8-6-26/h1-4,9-12H,5-8H2,(H2,22,23,24) XZOPDDDJHRZAKW-UHFFFAOYSA-N 580926 (2-(2-aminopyrimidin-5-yl)-6- morpholinopyridin-4-yl)(2- chlorophenyl)methanone::US11492348, Compound 138 Serine/threonine-protein kinase mTOR Homo sapiens 1100 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2112&target=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580926&enzyme=Serine%2Fthreonine-protein+kinase+mTOR&column=ki&startPg=0&Increment=50&submit=Search 146177570 475726761 1 MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW 1FAP,1NSG,2FAP,2GAQ,2RSE,3FAP,3JBZ,4DRH,4DRI,4DRJ,4FAP,4JSN,4JSP,4JSV,4JSX,4JT5,4JT6,5FLC,5H64,5WBH,5WBU,5WBY,5ZCS,6ZWM,6ZWO,7TZO,7UXC,7UXH,8ER6,8ER7,8ERA,8PPZ Serine/threonine-protein kinase mTOR MTOR_HUMAN P42345 Q4LE76 Q5TER1 Q6LE87 Q96QG3 Q9Y4I3 1224572 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)S(=O)(=O)c1ccccc1Cl InChI=1S/C19H18ClN5O3S/c20-15-3-1-2-4-17(15)29(26,27)14-9-16(13-11-22-19(21)23-12-13)24-18(10-14)25-5-7-28-8-6-25/h1-4,9-12H,5-8H2,(H2,21,22,23) JTYJEIBZRLYYQC-UHFFFAOYSA-N 580927 5-(4-((2-chlorophenyl)sulfonyl)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 139 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 16.0 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580927&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 156403570 475726762 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6 1224573 Nc1ncc(cn1)-c1cc(cc(n1)N1CCOCC1)N1CCCc2ccccc12 InChI=1S/C22H24N6O/c23-22-24-14-17(15-25-22)19-12-18(13-21(26-19)27-8-10-29-11-9-27)28-7-3-5-16-4-1-2-6-20(16)28/h1-2,4,6,12-15H,3,5,7-11H2,(H2,23,24,25) WETSTVOERCRPHB-UHFFFAOYSA-N 580928 5-(4-(3,4-dihydroquinolin-1(2H)-yl)-6- morpholinopyridin-2-yl)pyrimidin-2-amine::US11492348, Compound 140 RAC-alpha serine/threonine-protein kinase [1-472,474-480] Human 310 US Patent 10.7270/Q2ZS31CQ US11492348 Stocking, EM; Wrasidlo, WJ 11/8/2022 1/20/2023 Neuropore Therapies, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=580928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1331&target=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=580928&enzyme=RAC-alpha+serine%2Fthreonine-protein+kinase+%5B1-472%2C474-480%5D&column=ki&startPg=0&Increment=50&submit=Search 146177542 475726763 1 MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFYSASGTA RAC-alpha serine/threonine-protein kinase AKT1_HUMAN P31749 B2RAM5 B7Z5R1 Q9BWB6